{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":81,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":81,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"ed0f6a6f7fe7","filters":{"venue":"PharmacoEconomics - Open"}},"results":[{"id":"W3215778396","doi":"10.1007/s41669-021-00311-5","title":"Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries","year":2021,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Consumers, Health, Agriculture and Food Executive Agency; Directorate-General for Health and Consumers","keywords":"Health technology; Transparency (behavior); Scope (computer science); Negotiation; European union; Transformative learning; Business; Political science; Public economics; Process management; Medicine; Health care; Psychology; Computer science; Economics","authors":[{"name":"Anna-Maria Fontrier","is_ca":false},{"name":"Erica Visintin","is_ca":false},{"name":"Panos Kanavos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6845194897058882,"gpt":0.5941363569088085,"spread":0.09038313279707966,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07801989,0.000402628,0.001797618,0.01503582,0.001228949,0.006719367,0.001615638,0.001367095,0.002840437],"category_scores_gemma":[0.3105882,0.0009840961,0.003332493,0.02897089,0.00299472,0.005004801,0.005935847,0.00169661,0.0002313185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009086553,"about_ca_system_score_gemma":0.01119272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02913091,"about_ca_topic_score_gemma":0.02434633,"domain_scores_codex":[0.861445,0.07936329,0.03333124,0.006646003,0.0161338,0.00308075],"domain_scores_gemma":[0.5494497,0.3478701,0.06987765,0.01018736,0.02072913,0.001886114],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001582757,0.000177998,0.473756,0.06328865,0.005671776,0.0008862729,0.02756251,0.00410507,0.0003148236,0.0205556,0.004829683,0.397269],"study_design_scores_gemma":[0.0004766899,0.0004925973,0.7903033,0.1221212,0.007236778,0.001435373,0.02220461,0.001402007,0.0009150264,0.006464264,0.04675552,0.000192591],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.5250368,0.4145908,0.007765576,0.009525818,0.0002492057,0.001459032,0.005637609,0.00005351501,0.03568174],"genre_scores_gemma":[0.9414254,0.05050651,0.004420625,0.001494075,0.00003952038,0.0006113531,0.00128951,0.00003153404,0.0001814383],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.9219801,"threshold_uncertainty_score":0.4126135,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2952476208","doi":"10.1007/s41669-019-0143-2","title":"The Health System Costs of Potentially Inappropriate Prescribing: A Population-Based, Retrospective Cohort Study Using Linked Health Administrative Databases in Ontario, Canada","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; Bruyère; University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Retrospective cohort study; Medicine; Environmental health; Cohort; Population; Population health; Database; Family medicine; Business; Computer science","authors":[{"name":"Cody Black","is_ca":true},{"name":"Kednapa Thavorn","is_ca":true},{"name":"Doug Coyle","is_ca":true},{"name":"Lise M. Bjerre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1620565774407131,"gpt":0.4340308402737773,"spread":0.2719742628330641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001184993,0.0005183768,0.0006837574,0.002154527,0.00227456,0.001689937,0.001448126,0.000482307,0.00132643],"category_scores_gemma":[0.003712117,0.0006933698,0.001069926,0.006836162,0.0007095524,0.0006163101,0.001092468,0.0008345064,0.0001952447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03241467,"about_ca_system_score_gemma":0.03084349,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9911764,"about_ca_topic_score_gemma":0.9930167,"domain_scores_codex":[0.997832,0.0001702615,0.0002285467,0.0003672252,0.0009076105,0.0004944002],"domain_scores_gemma":[0.9956092,0.0002255826,0.001714626,0.0002125404,0.001681365,0.0005566317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003688839,0.00001746939,0.9978778,0.00003446406,0.000100167,0.00004892295,0.000206513,0.00008432941,0.00004115605,0.00003941302,0.0007365249,0.0007763157],"study_design_scores_gemma":[0.00001119078,0.00001382181,0.9986034,0.00003593278,0.00004929575,0.00005018185,0.0003325904,0.0002982268,0.00001702147,0.0000128926,0.000566853,0.000008589452],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730286,0.001262366,0.0002618272,0.0003904348,0.00001700427,0.0001617896,0.02317536,0.0000218168,0.001680722],"genre_scores_gemma":[0.9922543,0.0007097974,0.0002808823,0.0001392633,0.00001172454,0.00006441541,0.006060601,0.000006511182,0.0004725097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03241467,"threshold_uncertainty_score":0.235186,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3015688173","doi":"10.1007/s41669-020-00212-z","title":"Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Tianjin University; National Natural Science Foundation of China","keywords":"Anxiety; CLARITY; Relevance (law); Qualitative research; Psychology; China; Mental health; Population; Clinical psychology; Gerontology; Medicine; Psychiatry; Environmental health; Geography; Sociology; Social science; Political science","authors":[{"name":"Fan Yang","is_ca":false},{"name":"Shan Jiang","is_ca":true},{"name":"Xiaoning He","is_ca":false},{"name":"Hongchao Li","is_ca":false},{"name":"Hongyan Wu","is_ca":false},{"name":"Tiantian Zhang","is_ca":false},{"name":"Jing Wu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6214977604419405,"gpt":0.5467421121684448,"spread":0.07475564827349568,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01708824,0.0005361144,0.0009630761,0.001642707,0.004407968,0.001742596,0.001465437,0.001004544,0.003585529],"category_scores_gemma":[0.02286058,0.0007076919,0.0005916325,0.002149727,0.003851672,0.002987128,0.003120121,0.001569986,0.0002945676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006905891,"about_ca_system_score_gemma":0.009985423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0276713,"about_ca_topic_score_gemma":0.03251551,"domain_scores_codex":[0.9923224,0.00531504,0.0003192776,0.0004600167,0.0006187121,0.0009646452],"domain_scores_gemma":[0.9823262,0.01357498,0.00126761,0.0003753185,0.001518736,0.0009371325],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"qualitative","study_design_scores_codex":[0.00004921953,0.00004700615,0.01193652,0.0007673398,0.00001111713,0.0008577848,0.9783425,0.00003079965,0.0004285794,0.0005523774,0.0005138898,0.006462854],"study_design_scores_gemma":[0.000009716906,0.00008052837,0.008600976,0.0007390876,0.00001185011,0.0001976326,0.9855203,0.00009733382,0.000119886,0.0001975494,0.004405363,0.00001978441],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917524,0.001281826,0.001162211,0.002349811,0.0000442104,0.0004887696,0.0003525944,0.0000114678,0.002556589],"genre_scores_gemma":[0.9937446,0.001363816,0.001113065,0.001366062,0.00001354347,0.001043122,0.0001700911,0.00001590638,0.001169812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9829118,"threshold_uncertainty_score":0.09037232,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3103580978","doi":"10.1007/s41669-020-00241-8","title":"The Actual Operative Costs of Liver Transplantation and Normothermic Machine Perfusion in a Canadian Setting","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta","funders":"","keywords":"Liver transplantation; Procurement; Medicine; Transplantation; Machine perfusion; Total cost; Perfusion; Marginal cost; Operations management; Surgery; Emergency medicine; Business; Internal medicine; Economics; Accounting","authors":[{"name":"Alexandria N. Webb","is_ca":true},{"name":"Dayne L. Izquierdo","is_ca":true},{"name":"Dean T. Eurich","is_ca":true},{"name":"A. M. James Shapiro","is_ca":true},{"name":"David L. Bigam","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01892164509931704,"gpt":0.3280509178730727,"spread":0.3091292727737557,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001053554,0.0006388388,0.0003762632,0.002113221,0.001578858,0.001748411,0.001125032,0.0004523331,0.003947103],"category_scores_gemma":[0.00493713,0.0003169952,0.001159441,0.004141081,0.0006770364,0.0005379451,0.001078373,0.0008374295,0.0002216029],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1115744,"about_ca_system_score_gemma":0.07114677,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9733546,"about_ca_topic_score_gemma":0.9807212,"domain_scores_codex":[0.9976912,0.0003487468,0.00009064928,0.0001076071,0.00104833,0.0007135628],"domain_scores_gemma":[0.9974703,0.000350895,0.0004954503,0.00004227434,0.0008973336,0.0007438231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003297559,0.0004082189,0.6575201,0.002298535,0.001301415,0.002099226,0.001149041,0.06672924,0.003685921,0.01493911,0.03079965,0.2157721],"study_design_scores_gemma":[0.0002067386,0.0004373286,0.9536985,0.0004981736,0.0005152354,0.0014787,0.002080731,0.02177891,0.001166511,0.001135791,0.01682452,0.0001788795],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9563981,0.006758946,0.001575871,0.003494942,0.00009460392,0.000248004,0.007748254,0.00005946003,0.02362177],"genre_scores_gemma":[0.9903185,0.00306161,0.001872143,0.0001955051,0.00002966371,0.00004961733,0.002342026,0.00001597429,0.002114953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1115744,"threshold_uncertainty_score":0.8095325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4224952615","doi":"10.1007/s41669-022-00330-w","title":"Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis","year":2022,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Disease; Perspective (graphical); Medicine; Intensive care medicine; Medical costs; Health care; Pathology; Computer science; Political science","authors":[{"name":"Zachary K. Baldwin","is_ca":false},{"name":"Boshen Jiao","is_ca":false},{"name":"Anirban Basu","is_ca":false},{"name":"Joshua A. Roth","is_ca":false},{"name":"M. A. Bender","is_ca":false},{"name":"Zizi Elsisi","is_ca":false},{"name":"KATE JOHNSON","is_ca":false},{"name":"Emma M. Cousin","is_ca":false},{"name":"Scott D. Ramsey","is_ca":false},{"name":"Beth Devine","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01844975108290345,"gpt":0.3638666715506593,"spread":0.3454169204677558,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009145549,0.001434399,0.009219975,0.02599552,0.0005713435,0.003217148,0.00171505,0.001709615,0.004166211],"category_scores_gemma":[0.04774865,0.00095536,0.01333987,0.03064668,0.000636169,0.002566621,0.001786718,0.001305367,0.0002351035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005736931,"about_ca_system_score_gemma":0.007728389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01454692,"about_ca_topic_score_gemma":0.03379281,"domain_scores_codex":[0.9873506,0.003976311,0.005199457,0.0008192053,0.002240296,0.0004140173],"domain_scores_gemma":[0.9508615,0.0344111,0.0103249,0.0004456493,0.003565744,0.0003912155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004905708,0.00002564976,0.008312591,0.8931746,0.0552076,0.0002478987,0.0002210251,0.0005524122,0.0001198999,0.000704191,0.002911434,0.03803198],"study_design_scores_gemma":[0.0004948063,0.0002879792,0.03155173,0.6616667,0.2831134,0.001089208,0.0005994394,0.0007447634,0.0001927442,0.001238218,0.01893125,0.00008982536],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004972278,0.9900805,0.0002229989,0.0005969275,0.0000592213,0.0002505705,0.00324507,0.00001068885,0.0005616494],"genre_scores_gemma":[0.07614288,0.9195876,0.00103843,0.0006699242,0.00009771421,0.0007962879,0.001498998,0.00001319709,0.0001549681],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02599552,"threshold_uncertainty_score":0.04836684,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766253633","doi":"10.1007/s41669-017-0061-0","title":"The Healthcare Cost Burden of Acute Myocardial Infarction in Alberta, Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Canadian VIGOUR Centre; Institute of Health Economics; Alberta Hospital Edmonton; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Health care; Ambulatory care; Ambulatory; Emergency medicine; Acute care; Myocardial infarction; Population; Liberian dollar; Total cost; Medical emergency; Inpatient care; Environmental health; Business; Finance; Internal medicine","authors":[{"name":"Dat T. Tran","is_ca":true},{"name":"Arto Öhinmaa","is_ca":true},{"name":"Nguyễn Xuân Thành","is_ca":true},{"name":"Robert C. Welsh","is_ca":true},{"name":"Padma Kaul","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04275009629830681,"gpt":0.397792840425913,"spread":0.3550427441276062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000804327,0.0004102752,0.0003693264,0.002350847,0.001498706,0.001999947,0.001407063,0.0004027061,0.002638647],"category_scores_gemma":[0.003305544,0.0002286091,0.0005807553,0.006452665,0.0005455758,0.0004133581,0.0009623239,0.0008027729,0.0002078082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05319843,"about_ca_system_score_gemma":0.06930105,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9972681,"about_ca_topic_score_gemma":0.9976186,"domain_scores_codex":[0.9983383,0.0001207731,0.00009227185,0.0001002794,0.0009090011,0.0004393086],"domain_scores_gemma":[0.9978496,0.0001135176,0.0003923005,0.00003009937,0.001166631,0.0004478482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002346516,0.00007366542,0.925476,0.0004251415,0.0003076276,0.0003690616,0.0003854491,0.002071012,0.000252864,0.001073247,0.02554942,0.04378182],"study_design_scores_gemma":[0.00003646689,0.00002298502,0.9924412,0.0002238726,0.000103846,0.0001301303,0.0006165678,0.001387136,0.0000489309,0.0001513768,0.004818333,0.00001904774],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.86673,0.03300744,0.0009328257,0.0141868,0.000389327,0.0002097843,0.05667885,0.0001681402,0.02769686],"genre_scores_gemma":[0.9713867,0.009712314,0.001038838,0.001010098,0.0001319989,0.00004342536,0.01360052,0.00001917189,0.003056988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05319843,"threshold_uncertainty_score":0.3859834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2935761670","doi":"10.1007/s41669-019-0132-5","title":"Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Akebia Therapeutics; Otsuka Pharmaceutical","keywords":"Medicine; Observational study; Quality of life (healthcare); Cochrane Library; Randomized controlled trial; Intensive care medicine; Kidney disease; Population; MEDLINE; Dialysis; Pediatrics; Internal medicine; Environmental health","authors":[{"name":"Pablo E. Pérgola","is_ca":false},{"name":"Roberto Pecoits‐Filho","is_ca":false},{"name":"Wolfgang C. Winkelmayer­","is_ca":false},{"name":"Bruce Spinowitz","is_ca":false},{"name":"Samuel Rochette","is_ca":true},{"name":"Philippe Thompson‐Leduc","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Gigi Shafai","is_ca":false},{"name":"Ana Bozas","is_ca":false},{"name":"Myrlene Sanon","is_ca":false},{"name":"Holly B. Krasa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1412128731212003,"gpt":0.4430817841296246,"spread":0.3018689110084243,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005718083,0.001102468,0.00847036,0.008196286,0.0005126775,0.002616724,0.001398118,0.001594094,0.002953732],"category_scores_gemma":[0.03269917,0.0008920344,0.007938148,0.008393433,0.0006624524,0.001595043,0.00108728,0.001153927,0.0001352354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003768302,"about_ca_system_score_gemma":0.006978326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00839716,"about_ca_topic_score_gemma":0.01975058,"domain_scores_codex":[0.9941223,0.002313302,0.001972499,0.0003914152,0.001028224,0.0001723547],"domain_scores_gemma":[0.9702191,0.02183699,0.00580798,0.0002441341,0.001656588,0.0002353013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0003460766,0.00002534151,0.002064851,0.9445553,0.02105046,0.00009005103,0.0001235763,0.0001342116,0.00006001793,0.0001880162,0.001120726,0.03024121],"study_design_scores_gemma":[0.0004684733,0.0003745049,0.01424803,0.8242365,0.1458938,0.0006006849,0.0003403524,0.0002319536,0.000147247,0.000451235,0.01294338,0.00006400282],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001877398,0.9972541,0.00006347782,0.0001632226,0.0000472138,0.0001333396,0.0002755479,0.000003727594,0.0001820003],"genre_scores_gemma":[0.0285201,0.9700311,0.0003875139,0.0003288284,0.00007631277,0.0003495342,0.0002270334,0.000003550463,0.00007597264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00847036,"threshold_uncertainty_score":0.03024048,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2555011614","doi":"10.1007/s41669-016-0007-y","title":"Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015","year":2016,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicaid; Reimbursement; Quarter (Canadian coin); Medical prescription; Pharmacy; Medicine; Prescription drug; Population; Family medicine; Environmental health; Pharmacology; Health care; Geography; Economic growth; Economics","authors":[{"name":"Ziyad S. Almalki","is_ca":false},{"name":"Xiaomeng Yue","is_ca":false},{"name":"Ying Xia","is_ca":false},{"name":"Patricia R. Wigle","is_ca":false},{"name":"Jeff J. Guo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1063738117336394,"gpt":0.4256349832234699,"spread":0.3192611714898306,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001033231,0.0001795249,0.0002075078,0.001447379,0.0005962831,0.0009023348,0.0004644166,0.0004711966,0.0014697],"category_scores_gemma":[0.003666806,0.0002200411,0.0005963791,0.002748894,0.0003412445,0.001231798,0.001084431,0.001014595,0.0002514254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00273346,"about_ca_system_score_gemma":0.002412541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1311992,"about_ca_topic_score_gemma":0.1601831,"domain_scores_codex":[0.9992493,0.00008983045,0.0000829197,0.00008408857,0.0002704841,0.0002233647],"domain_scores_gemma":[0.9975857,0.0001786398,0.001333026,0.0000376782,0.0003831188,0.0004818199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004647494,0.0001090005,0.9871688,0.00002651076,0.00005518824,0.0001109531,0.000601086,0.0001477449,0.0001010523,0.0001420921,0.003496639,0.007994412],"study_design_scores_gemma":[0.00000247585,0.00002608995,0.9975675,0.00002378622,0.00001136076,0.00008367976,0.0005187474,0.0001595806,0.00004093095,0.00001704844,0.001544501,0.000004274749],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894967,0.0008698278,0.00006159634,0.001738447,0.00001437096,0.00002421251,0.005919566,0.00001219001,0.001863026],"genre_scores_gemma":[0.9901688,0.00159976,0.0001248162,0.0005547088,0.00004598783,0.00003756095,0.006619769,0.000007109626,0.0008414748],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1311992,"threshold_uncertainty_score":0.2608711,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2933306415","doi":"10.1007/s41669-019-0131-6","title":"Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Dulaglutide; Semaglutide; Type 2 diabetes; Medicine; Internal medicine; Diabetes mellitus; Endocrinology; Exenatide; Liraglutide","authors":[{"name":"Pierre Johansen","is_ca":false},{"name":"Jonas Håkan‐Bloch","is_ca":false},{"name":"Aiden R. Liu","is_ca":false},{"name":"Peter G. Bech","is_ca":false},{"name":"Sofie Persson","is_ca":false},{"name":"Lawrence A. Leiter","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04761554358127133,"gpt":0.3363003955237773,"spread":0.288684851942506,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002282245,0.0007029256,0.001184749,0.00115863,0.0008596919,0.002191561,0.001524479,0.0008917387,0.002880638],"category_scores_gemma":[0.009317523,0.0004451732,0.002386902,0.001691106,0.0005160725,0.0007540635,0.0007804917,0.001105447,0.00008930717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05559682,"about_ca_system_score_gemma":0.04831172,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9429981,"about_ca_topic_score_gemma":0.9375743,"domain_scores_codex":[0.9982128,0.0007085394,0.00008083741,0.0001342417,0.0004723542,0.0003913399],"domain_scores_gemma":[0.9966244,0.001642611,0.0003834197,0.00007917777,0.0008322232,0.0004382136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01637124,0.0007184474,0.05508992,0.001615898,0.003697185,0.0007544782,0.0001930294,0.8181928,0.001316308,0.008397202,0.00595337,0.08770015],"study_design_scores_gemma":[0.006194151,0.003324438,0.1041022,0.0009423571,0.006239861,0.0004936432,0.0009674214,0.8612828,0.001779465,0.006737315,0.007593393,0.0003428636],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9478087,0.01740701,0.003192911,0.00365073,0.000113707,0.0006452893,0.007128343,0.0001305589,0.01992263],"genre_scores_gemma":[0.9946247,0.002220447,0.001090884,0.0002423713,0.000009326392,0.00005047958,0.000807505,0.00001075006,0.000943417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05700195,"threshold_uncertainty_score":0.4033851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2801866300","doi":"10.1007/s41669-018-0083-2","title":"Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; International Collaboration On Repair Discoveries; Simon Fraser University; Vancouver Coastal Health","funders":"National Institute for Health and Care Research; Ontario Stroke Network; SFU Community Trust Endowment Fund; Health Technology Assessment Programme; Simon Fraser University; Tavistock Trust for Aphasia; EuroQol Research Foundation; Research for Patient Benefit Programme; Ontario Ministry of Health and Long-Term Care","keywords":"Valuation (finance); Preference; Process (computing); Quality of life (healthcare); Psychology; Conceptual framework; Quality (philosophy); Applied psychology; Computer science; Medicine; Nursing; Business; Sociology; Social science","authors":[{"name":"David G. T. Whitehurst","is_ca":true},{"name":"Nicholas Latimer","is_ca":false},{"name":"Aura Kagan","is_ca":false},{"name":"Rebecca Palmer","is_ca":false},{"name":"Nina Simmons‐Mackie","is_ca":false},{"name":"J. Charles Victor","is_ca":true},{"name":"Jeffrey S. Hoch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6861002413643779,"gpt":0.5569994370974879,"spread":0.12910080426689,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09218862,0.0007304052,0.0008430869,0.004297312,0.001183877,0.004798771,0.001159741,0.001016856,0.003271489],"category_scores_gemma":[0.1861878,0.0005485015,0.001731603,0.007044991,0.001932978,0.0025336,0.00258092,0.002148524,0.0005450761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0104138,"about_ca_system_score_gemma":0.01475228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.113466,"about_ca_topic_score_gemma":0.151537,"domain_scores_codex":[0.9457759,0.02730341,0.007719741,0.001204965,0.01693026,0.001065765],"domain_scores_gemma":[0.8546043,0.08974557,0.009429361,0.006448074,0.03871512,0.001057492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"qualitative","study_design_scores_codex":[0.001600274,0.0009654998,0.09670766,0.004703368,0.0004159384,0.000698922,0.0144498,0.008018443,0.003271666,0.02148077,0.01318298,0.8345047],"study_design_scores_gemma":[0.000938716,0.003231847,0.777078,0.009147591,0.0006711033,0.001742411,0.01632655,0.0121842,0.01291182,0.01163033,0.1534456,0.0006918635],"study_design_candidate":"qualitative","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.626901,0.02378295,0.2375181,0.00738643,0.0004830173,0.0268052,0.02260914,0.0004103054,0.05410395],"genre_scores_gemma":[0.5554609,0.009731197,0.4097706,0.000963287,0.00006913619,0.01189633,0.008928985,0.0002055524,0.002974014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.113466,"threshold_uncertainty_score":0.4875458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2942619274","doi":"10.1007/s41669-019-0142-3","title":"A Systematic Review of the Health Economics of Pompe Disease","year":2019,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Audentes Therapeutics","keywords":"Medicine; Enzyme replacement therapy; Life expectancy; Disease; Quality of life (healthcare); Quality-adjusted life year; Health economics; MEDLINE; Health care; Economic evaluation; Systematic review; Indirect costs; Pediatrics; Cost effectiveness; Family medicine; Physical therapy; Environmental health; Public health; Internal medicine; Nursing; Pathology","authors":[{"name":"Benedikt Schoser","is_ca":false},{"name":"Andreas Hahn","is_ca":false},{"name":"Emma S. James","is_ca":false},{"name":"Digant Gupta","is_ca":false},{"name":"Matthew Gitlin","is_ca":false},{"name":"Suyash Prasad","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1245908268084915,"gpt":0.473416101944346,"spread":0.3488252751358544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01163685,0.002066501,0.009170433,0.01398027,0.0006330153,0.00358534,0.0018191,0.001635165,0.006985295],"category_scores_gemma":[0.06219681,0.001084824,0.009947115,0.01138091,0.0008125733,0.002216819,0.001682236,0.001516241,0.0004047106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006106316,"about_ca_system_score_gemma":0.01323741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009080621,"about_ca_topic_score_gemma":0.01992094,"domain_scores_codex":[0.9870684,0.005628559,0.004338362,0.0006617752,0.00194711,0.0003556751],"domain_scores_gemma":[0.9540066,0.03458475,0.007285736,0.0005597059,0.003253588,0.0003096014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002274777,0.00001368864,0.0006599324,0.9554549,0.01598181,0.0001171894,0.00009657517,0.0002235127,0.00007336451,0.0004209569,0.001404929,0.02532557],"study_design_scores_gemma":[0.0003259228,0.0001666577,0.003463665,0.9051039,0.07510531,0.0003301679,0.0001405521,0.0001328135,0.0001043453,0.0006757184,0.01441776,0.00003328503],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001435318,0.9953048,0.0002622689,0.0004788935,0.0001530539,0.0004914379,0.001203136,0.0000094381,0.0006615666],"genre_scores_gemma":[0.02013893,0.9769071,0.0008452623,0.0005525284,0.0001228938,0.0007649738,0.0005032488,0.000009057165,0.0001560567],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01398027,"threshold_uncertainty_score":0.06154227,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3210263997","doi":"10.1007/s41669-021-00309-z","title":"Community Distribution of Naloxone: A Systematic Review of Economic Evaluations","year":2021,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Impact","funders":"","keywords":"(+)-Naloxone; EconLit; Medicine; Quality (philosophy); Economic evaluation; MEDLINE; Actuarial science; Business; Opioid; Political science","authors":[{"name":"Nelda Cherrier","is_ca":true},{"name":"Joanne Kearon","is_ca":true},{"name":"Robin Tetreault","is_ca":true},{"name":"Sophiya Garasia","is_ca":true},{"name":"G. Emmanuel Guindon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1185071507510415,"gpt":0.4933644225600569,"spread":0.3748572718090154,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04974859,0.002676844,0.01498777,0.01910853,0.001125708,0.005450575,0.003004196,0.00318157,0.005308699],"category_scores_gemma":[0.1912784,0.001822276,0.01406407,0.01596902,0.001637997,0.004154233,0.002571921,0.003021235,0.0003066483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01289743,"about_ca_system_score_gemma":0.01963923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007758616,"about_ca_topic_score_gemma":0.01939823,"domain_scores_codex":[0.9416332,0.031905,0.01498851,0.001680084,0.008794547,0.0009986324],"domain_scores_gemma":[0.8069835,0.156957,0.02057651,0.002151692,0.01240048,0.0009308504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0007167725,0.00003654244,0.0005252583,0.944087,0.01859386,0.00009832616,0.000133505,0.0002616046,0.00007018401,0.0004362221,0.001063541,0.03397725],"study_design_scores_gemma":[0.0008919379,0.0003890693,0.002448343,0.8865234,0.09871799,0.0002247459,0.0002964183,0.0003051031,0.0001970082,0.0007836343,0.009169642,0.00005269223],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001629226,0.9949315,0.0004583524,0.0006088114,0.0001783095,0.001264715,0.0004385884,0.00001339533,0.0004770845],"genre_scores_gemma":[0.04023171,0.9524778,0.002519287,0.0007875714,0.0001466434,0.003308826,0.0003638359,0.00001696927,0.000147397],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04974859,"threshold_uncertainty_score":0.2630988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2744741417","doi":"10.1007/s41669-017-0049-9","title":"Direct Mapping of the QLQ-C30 to EQ-5D Preferences: A Comparison of Regression Methods","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Statistics; Logistic regression; Ordinary least squares; Regression diagnostic; Regression analysis; Segmented regression; Censored regression model; Regression; Mathematics; Econometrics; Local regression; Cross-sectional regression; Linear regression; Polynomial regression","authors":[{"name":"Ralph Crott","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.8025354787775343,"gpt":0.6055012823377216,"spread":0.1970341964398127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03392582,0.001666885,0.001588766,0.00349426,0.0002924025,0.00130955,0.001883893,0.001035572,0.0044689],"category_scores_gemma":[0.08647709,0.000705843,0.002708436,0.003844249,0.0004345356,0.001642574,0.002227136,0.002124516,0.001594777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009009179,"about_ca_system_score_gemma":0.0009064422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006881376,"about_ca_topic_score_gemma":0.003278991,"domain_scores_codex":[0.9777372,0.01774265,0.0007278689,0.001900498,0.001662292,0.0002294666],"domain_scores_gemma":[0.9185762,0.07275154,0.002462135,0.002776738,0.003218416,0.0002148956],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.003135902,0.000540933,0.07005507,0.001691475,0.003349254,0.0001408069,0.0006356928,0.2178191,0.001362155,0.006329183,0.003453999,0.6914864],"study_design_scores_gemma":[0.0003856092,0.001163301,0.04880038,0.0004463017,0.0006038904,0.0002762864,0.0004385901,0.9363651,0.001804663,0.005692889,0.003867148,0.0001559322],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2056093,0.00820988,0.7769536,0.0009064723,0.0002132367,0.000674297,0.001801952,0.001644196,0.003986997],"genre_scores_gemma":[0.6005578,0.005821693,0.3848126,0.0002794111,0.0001799945,0.001512489,0.002436441,0.001179427,0.003220104],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9660742,"threshold_uncertainty_score":0.179419,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4295905156","doi":"10.1007/s41669-022-00363-1","title":"Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Novartis (Canada); EVERSANA (Canada); Memorial University of Newfoundland; University of British Columbia; Queen's University","funders":"Novartis Pharmaceuticals Canada","keywords":"Relapsing remitting; Ofatumumab; Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Internal medicine; Psychiatry","authors":[{"name":"Moogeh Baharnoori","is_ca":true},{"name":"Virender Bhan","is_ca":true},{"name":"Fraser Clift","is_ca":true},{"name":"Kimberly Thomas","is_ca":true},{"name":"Soukaïna Mouallif","is_ca":true},{"name":"Nicholas Adlard","is_ca":false},{"name":"Philip Cooney","is_ca":false},{"name":"François Blanchette","is_ca":true},{"name":"Barkha P. Patel","is_ca":true},{"name":"Daniel Grima","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2283981779288735,"gpt":0.4132400132269685,"spread":0.184841835298095,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002553327,0.0009321665,0.001307737,0.002066592,0.001057613,0.001757486,0.001743928,0.0008956797,0.003897291],"category_scores_gemma":[0.01074279,0.0005585462,0.002668127,0.002894172,0.0005612003,0.0005099096,0.0008103857,0.001199967,0.0001462078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08088894,"about_ca_system_score_gemma":0.09494025,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9800939,"about_ca_topic_score_gemma":0.9712625,"domain_scores_codex":[0.9983557,0.0005978613,0.00007414458,0.0001527356,0.0004364332,0.0003831346],"domain_scores_gemma":[0.9960356,0.001442607,0.0003981168,0.00008918872,0.001483271,0.0005511807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01163288,0.000868983,0.1355696,0.003415765,0.007935837,0.0009368504,0.0003021439,0.7266483,0.0009011269,0.01868263,0.02407611,0.06902973],"study_design_scores_gemma":[0.006073771,0.001411111,0.1178333,0.001169884,0.007927898,0.0004663314,0.0008057254,0.8449687,0.0006927905,0.005480406,0.01290698,0.0002631518],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9164658,0.0213277,0.005001972,0.007664021,0.0002499217,0.001773432,0.02652692,0.0001778793,0.02081227],"genre_scores_gemma":[0.9877468,0.003622779,0.00250757,0.0003797027,0.00002750774,0.0001887748,0.003861632,0.00001959185,0.001645516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08088894,"threshold_uncertainty_score":0.5868931,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3121637752","doi":"10.1007/s41669-021-00257-8","title":"The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"Alberta Innovates; Sanofi","keywords":"Medicine; Secondary prevention; Dyslipidemia; Health care; Disease; Disease burden; Cardiovascular event; Internal medicine; Emergency medicine; Pediatrics","authors":[{"name":"Dat T. Tran","is_ca":true},{"name":"Dan Palfrey","is_ca":true},{"name":"Robert C. Welsh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03160288090312003,"gpt":0.3514413774480248,"spread":0.3198384965449048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007062945,0.0003356093,0.0002192846,0.001290336,0.000324318,0.0008872498,0.0004956082,0.0003564845,0.001260645],"category_scores_gemma":[0.00346388,0.0001602351,0.0006606757,0.00201606,0.0002005359,0.000466905,0.0006710015,0.0005820495,0.0001442097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003732512,"about_ca_system_score_gemma":0.00335313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3778711,"about_ca_topic_score_gemma":0.515881,"domain_scores_codex":[0.9992968,0.0001552652,0.00009598014,0.00007061262,0.0002545831,0.000126727],"domain_scores_gemma":[0.9990502,0.00009369913,0.00041674,0.00002554132,0.0002557778,0.0001580191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004911694,0.00003276571,0.9907978,0.00005254409,0.0002310608,0.00004935542,0.00005016695,0.0007077347,0.00002657576,0.0001468282,0.002569832,0.005286179],"study_design_scores_gemma":[0.00001699281,0.00003876458,0.9953999,0.00009106181,0.00009809717,0.0001530977,0.0002157102,0.00189226,0.00002849872,0.0001275367,0.001929887,0.000008202279],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665981,0.004723413,0.0005049504,0.001762407,0.00007030091,0.00009371984,0.02195571,0.00002466951,0.004266772],"genre_scores_gemma":[0.9887004,0.0009963383,0.0006990968,0.0002241489,0.00004482691,0.00004185422,0.008817124,0.000002704182,0.0004736133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3778711,"threshold_uncertainty_score":0.7513433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2601604409","doi":"10.1007/s41669-017-0018-3","title":"Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Cancer Care Ontario; St. Michael's Hospital","funders":"","keywords":"Consistency (knowledge bases); Activity-based costing; Drug pricing; Medicine; Political science; Actuarial science; Business; Accounting; Computer science","authors":[{"name":"Lisa Masucci","is_ca":true},{"name":"Jaclyn Beca","is_ca":true},{"name":"Mona Sabharwal","is_ca":false},{"name":"Jeffrey S. Hoch","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7627049803111466,"gpt":0.6465122802148523,"spread":0.1161927000962943,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7852393,0.002596354,0.007662934,0.03795004,0.007303895,0.02218364,0.009231211,0.009031983,0.00440032],"category_scores_gemma":[0.9431101,0.004849601,0.009926333,0.05213315,0.009117897,0.009115097,0.009503063,0.006167913,0.001340744],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04079915,"about_ca_system_score_gemma":0.1174935,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02564492,"about_ca_topic_score_gemma":0.05030428,"domain_scores_codex":[0.07088842,0.5881061,0.2472064,0.01184293,0.07854749,0.003408631],"domain_scores_gemma":[0.02377406,0.7332744,0.0922134,0.03384719,0.1153245,0.001566399],"domain_codex":"methods","domain_gemma":"methods","domain_candidate":"methods","domain_consensus":"methods","study_design_codex":"systematic_review","study_design_gemma":"observational","study_design_scores_codex":[0.00380908,0.0002490611,0.03200168,0.4992923,0.01749041,0.001427231,0.04022764,0.004244989,0.00226301,0.03467729,0.09477482,0.2695425],"study_design_scores_gemma":[0.002654927,0.001134603,0.04464823,0.5591845,0.01856439,0.001320473,0.0192286,0.008357392,0.005203272,0.06006106,0.2783666,0.001276138],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.04920618,0.3725695,0.1670848,0.1689711,0.03368461,0.1518117,0.02212767,0.001166,0.03337844],"genre_scores_gemma":[0.323491,0.07018315,0.3312085,0.02763955,0.004765714,0.231611,0.005781191,0.0008926486,0.004427306],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9743551,"threshold_uncertainty_score":0.29602,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2887988025","doi":"10.1007/s41669-018-0089-9","title":"Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Pharmaceuticals; Janssen Scientific Affairs","keywords":"Paliperidone Palmitate; Medicaid; Paliperidone; Schizophrenia (object-oriented programming); Medicine; Pharmacy; Medical costs; Health care; Emergency medicine; Demography; Psychiatry; Family medicine; Antipsychotic; Political science","authors":[{"name":"Bruno Émond","is_ca":true},{"name":"Kruti Joshi","is_ca":false},{"name":"Antoine C. El Khoury","is_ca":false},{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Dominic Pilon","is_ca":true},{"name":"Neeta Tandon","is_ca":false},{"name":"Hela Romdhani","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05890968230085235,"gpt":0.3706249907799557,"spread":0.3117153084791033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008218121,0.0001869964,0.0003222623,0.0007190423,0.0005407788,0.0005389448,0.0003095525,0.000502817,0.0009260305],"category_scores_gemma":[0.002288771,0.0002088566,0.0007820309,0.0009691669,0.0001703377,0.0004932454,0.0005791362,0.0007548796,0.0001114861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009849708,"about_ca_system_score_gemma":0.0007118253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05595621,"about_ca_topic_score_gemma":0.06127281,"domain_scores_codex":[0.9994922,0.0001075227,0.00008739825,0.00008181176,0.0001074842,0.0001235517],"domain_scores_gemma":[0.9989306,0.0001007655,0.0006735213,0.00004042755,0.0000814495,0.0001731593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000151489,0.00009668132,0.9983798,0.000005775883,0.00005241914,0.00001492208,0.0000570088,0.00005465923,0.00004987984,0.000007390582,0.00006857164,0.001061385],"study_design_scores_gemma":[0.000008082288,0.00006733592,0.9995189,0.000006295435,0.00001940496,0.00002066798,0.0001064374,0.0001955267,0.00001384058,0.000005691234,0.00003564553,0.000002191809],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995334,0.00006720898,0.0000114492,0.00003901631,0.000001957359,0.000004806341,0.0002631539,0.000001060131,0.0000778813],"genre_scores_gemma":[0.9992626,0.00007041392,0.00003408214,0.00004285679,0.000004176654,0.00001205851,0.0004869231,7.259085e-7,0.0000861791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05595621,"threshold_uncertainty_score":0.111261,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2956056819","doi":"10.1007/s41669-019-0154-z","title":"US Integrated Delivery Networks Perspective on Economic Burden of Patients with Treatment-Resistant Depression: A Retrospective Matched-Cohort Study","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Treatment of Major Depression","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Major depressive disorder; Medicine; Depression (economics); Retrospective cohort study; Cohort; Treatment-resistant depression; Internal medicine; Confidence interval; Propensity score matching; Comorbidity; Rate ratio; Psychiatry; Mood","authors":[{"name":"Holly Szukis","is_ca":false},{"name":"Kruti Joshi","is_ca":false},{"name":"David Singer","is_ca":false},{"name":"John J. Sheehan","is_ca":false},{"name":"Jennifer W. Wu","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Paul E. Greenberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01090551635820826,"gpt":0.3006798630846841,"spread":0.2897743467264759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001408451,0.000311239,0.0003902339,0.001389334,0.0006280506,0.0008563367,0.0004726879,0.0004243903,0.001958577],"category_scores_gemma":[0.004545436,0.000384951,0.0007686913,0.002539266,0.0002301821,0.0008919826,0.0008770837,0.0006545893,0.0002834217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001009362,"about_ca_system_score_gemma":0.0007635421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01885877,"about_ca_topic_score_gemma":0.02235175,"domain_scores_codex":[0.9986989,0.0004402387,0.0001762079,0.0002905316,0.0001880815,0.0002059579],"domain_scores_gemma":[0.9973351,0.0002326622,0.001687313,0.0002408608,0.0002511061,0.0002528758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008803688,0.000044714,0.9986548,0.000007976238,0.0001144629,0.00004364201,0.00004935032,0.0000323924,0.0000248056,0.00004330953,0.0002234042,0.0006729332],"study_design_scores_gemma":[0.00003733529,0.0002133112,0.9974973,0.00003044716,0.0001364154,0.0003382615,0.0004184168,0.0006025205,0.00003412748,0.00006956807,0.0006146219,0.000007706894],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965094,0.0004178203,0.0002460384,0.0001421063,0.00001206482,0.00007117629,0.002105256,0.000003107524,0.0004929704],"genre_scores_gemma":[0.9977376,0.0002363876,0.0002444206,0.0001359647,0.0000227202,0.00007359086,0.001413915,0.000002317237,0.0001329926],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01885877,"threshold_uncertainty_score":0.037498,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4321490951","doi":"10.1007/s41669-023-00396-0","title":"Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"AstraZeneca (Canada); Princess Margaret Cancer Centre; University of Toronto; University Health Network; Hôpital Charles-Le Moyne; William Osler Health System","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; Adjuvant; Lung cancer; Oncology; Internal medicine; Quality of life (healthcare); Disease; Cost effectiveness; Quality-adjusted life year; Cancer; Epidermal growth factor receptor","authors":[{"name":"Andre Verhoek","is_ca":false},{"name":"Parneet Cheema","is_ca":true},{"name":"Barbara Melosky","is_ca":false},{"name":"Benoit Samson","is_ca":true},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Filippo de Marinis","is_ca":false},{"name":"Thomas John","is_ca":false},{"name":"Yi‐Long Wu","is_ca":false},{"name":"Bart Heeg","is_ca":false},{"name":"Nadia Van Dalfsen","is_ca":false},{"name":"Benjamin Bracke","is_ca":false},{"name":"Miguel Miranda","is_ca":false},{"name":"Simon Shaw","is_ca":false},{"name":"Daniel Moldaver","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04069752551216663,"gpt":0.4178555083762873,"spread":0.3771579828641207,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002838182,0.0007078275,0.001156611,0.0003825358,0.0002168796,0.0009511251,0.0009173179,0.0006114851,0.001724121],"category_scores_gemma":[0.008120291,0.0003244513,0.00213861,0.0005462549,0.000332078,0.0005293049,0.0004710412,0.000839212,0.00009082145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007663049,"about_ca_system_score_gemma":0.005432114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1113831,"about_ca_topic_score_gemma":0.08333187,"domain_scores_codex":[0.999255,0.0004470318,0.00003612013,0.00007995868,0.00007496945,0.0001070244],"domain_scores_gemma":[0.9978518,0.001538343,0.0001982914,0.00005916627,0.0001418636,0.0002104575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.03219798,0.001559283,0.05827659,0.0008592337,0.00234275,0.0003508679,0.0001073556,0.8550817,0.001125643,0.00298554,0.001388217,0.04372482],"study_design_scores_gemma":[0.004754839,0.01263108,0.04542714,0.0002413209,0.00333825,0.0002123049,0.0001962878,0.9280766,0.001151028,0.002070333,0.001837396,0.00006336771],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883736,0.002956617,0.003138515,0.0007862595,0.00003584953,0.0004304414,0.001986684,0.00002970183,0.002262448],"genre_scores_gemma":[0.997838,0.0003912927,0.0007447845,0.00005313783,0.000005221943,0.00006959735,0.0007009657,0.000002213671,0.0001948157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1113831,"threshold_uncertainty_score":0.2214696,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4367175132","doi":"10.1007/s41669-023-00415-0","title":"Humanistic and Economic Burden of IgA Nephropathy: Systematic Literature Reviews and Narrative Synthesis","year":2023,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Systematic review; Medicine; Critical appraisal; Checklist; Grey literature; MEDLINE; Nephropathy; Quality of life (healthcare); Economic evaluation; Health care; Family medicine; Intensive care medicine; Alternative medicine; Psychology; Nursing; Pathology; Political science","authors":[{"name":"Kenar D. Jhaveri","is_ca":false},{"name":"Mark Bensink","is_ca":false},{"name":"Martin Bunke","is_ca":false},{"name":"Jonathon A. Briggs","is_ca":false},{"name":"David M.W. Cork","is_ca":false},{"name":"Anushya Jeyabalan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08089463607554481,"gpt":0.4101879574652315,"spread":0.3292933213896867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08765125,0.002908764,0.01015233,0.02564909,0.001184335,0.008719265,0.002743977,0.003308309,0.007128742],"category_scores_gemma":[0.2885719,0.001803382,0.01102447,0.0168025,0.00246625,0.006005446,0.004856355,0.002885895,0.000405304],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01108553,"about_ca_system_score_gemma":0.02962602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006772599,"about_ca_topic_score_gemma":0.01529581,"domain_scores_codex":[0.8928896,0.05917679,0.0292943,0.003288444,0.01371237,0.001638612],"domain_scores_gemma":[0.7269853,0.2162059,0.0367026,0.003780268,0.01508122,0.001244713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002174743,0.0000188653,0.0007172445,0.9547601,0.01463525,0.00009911244,0.0005169757,0.0002655041,0.0000641188,0.001542567,0.002021156,0.02514157],"study_design_scores_gemma":[0.0002268951,0.0001173436,0.001626202,0.9313588,0.04558161,0.0001928797,0.0007200596,0.000213613,0.0001277566,0.002603726,0.01717694,0.00005423947],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002145057,0.9853768,0.0016603,0.00376148,0.0007918169,0.002618679,0.002202834,0.00002928214,0.001413778],"genre_scores_gemma":[0.06481368,0.9113717,0.007725528,0.004637393,0.0008020108,0.009079895,0.001174892,0.00003050861,0.0003643828],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.08765125,"threshold_uncertainty_score":0.4635497,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3203942868","doi":"10.1007/s41669-021-00300-8","title":"Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Evolocumab; Medicine; Ezetimibe; Familial hypercholesterolemia; Dyslipidemia; Statin; Internal medicine; Quality-adjusted life year; Alirocumab; Cost effectiveness; Cholesterol; Disease; Lipoprotein","authors":[{"name":"Ahmed Alghamdi","is_ca":false},{"name":"Bander Balkhi","is_ca":false},{"name":"Abdulaziz Altowaijri","is_ca":false},{"name":"Nasser Alshehri","is_ca":false},{"name":"Lewis Ralph","is_ca":false},{"name":"Emily-Ruth Marriott","is_ca":false},{"name":"Michael Urbich","is_ca":false},{"name":"Fawaz Aljanad","is_ca":false},{"name":"Rima Aziziyeh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1132914764465246,"gpt":0.427569372084309,"spread":0.3142778956377844,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004094328,0.0007510053,0.0009384767,0.0009998374,0.0001563851,0.0009589933,0.000622208,0.0007633923,0.003250927],"category_scores_gemma":[0.01249065,0.0003783033,0.002387794,0.0006814136,0.0002851455,0.0006586639,0.0007666675,0.0007850867,0.0001183241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00564916,"about_ca_system_score_gemma":0.003029227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02961736,"about_ca_topic_score_gemma":0.01632224,"domain_scores_codex":[0.9982685,0.001340326,0.00007423397,0.00008363887,0.0001215796,0.0001116225],"domain_scores_gemma":[0.9944885,0.003971975,0.0007001341,0.0001070315,0.0004275216,0.0003048391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0358463,0.001156921,0.07747707,0.004689063,0.009855717,0.001032762,0.0002741457,0.7813304,0.001982312,0.006814487,0.003982415,0.07555829],"study_design_scores_gemma":[0.01001398,0.01258378,0.08414384,0.00208449,0.01276711,0.001320002,0.0009777793,0.8644638,0.001912387,0.004263435,0.005308332,0.0001610844],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762271,0.01362681,0.003129871,0.001799494,0.00008077098,0.0003586441,0.002040824,0.00003283713,0.002703804],"genre_scores_gemma":[0.997135,0.00124694,0.0008320912,0.0001145905,0.00001055125,0.00005789738,0.0004066803,0.000002907893,0.0001933376],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02961736,"threshold_uncertainty_score":0.05888993,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2752473968","doi":"10.1007/s41669-017-0051-2","title":"The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Michael's Hospital; University of Toronto; Cancer Care Ontario; University of Manitoba; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Retrospective cohort study; Cancer; Confidence interval; Propensity score matching; Internal medicine; Cohort; Primary tumor; Proportional hazards model; Cancer registry; Population; Oncology; Clinical trial; Surgery; Metastasis","authors":[{"name":"Malek B. Hannouf","is_ca":true},{"name":"Eric Winquist","is_ca":true},{"name":"Salaheddin M. Mahmud","is_ca":true},{"name":"Muriel Brackstone","is_ca":true},{"name":"Sisira Sarma","is_ca":true},{"name":"George Rodrigues","is_ca":true},{"name":"Peter K. Rogan","is_ca":true},{"name":"Jeffrey S. Hoch","is_ca":true},{"name":"Gregory S. Zaric","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03977007119584718,"gpt":0.4071142063706688,"spread":0.3673441351748216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003117448,0.0003101465,0.0004718605,0.001087102,0.0006506476,0.0008324725,0.0007132683,0.0005383416,0.001354158],"category_scores_gemma":[0.006866395,0.0004030003,0.0008706934,0.001661796,0.0004561648,0.00053566,0.0006301798,0.0006069043,0.0001916662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001009563,"about_ca_system_score_gemma":0.0008571343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01297464,"about_ca_topic_score_gemma":0.01315806,"domain_scores_codex":[0.9982482,0.000635963,0.0001499975,0.0004703333,0.0002871333,0.0002083639],"domain_scores_gemma":[0.9964431,0.0006281986,0.00158577,0.0006431369,0.0003126428,0.0003871027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003555084,0.00003729704,0.9984044,0.000009034074,0.0001614212,0.00009933762,0.00003212754,0.00005597155,0.00007799345,0.00005164875,0.00009144117,0.0006237985],"study_design_scores_gemma":[0.000078182,0.0003357114,0.9969438,0.0000162687,0.0002635974,0.0005651348,0.0001256247,0.001028047,0.00009939115,0.00009637869,0.0004381319,0.000009706167],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998504,0.0002780484,0.0002071819,0.00007076828,0.000008634192,0.00003302043,0.0005966059,0.000002216203,0.0002994893],"genre_scores_gemma":[0.9992833,0.0001017872,0.0001257448,0.00003653307,0.00001301055,0.00001840084,0.0003563913,0.000001556727,0.00006336994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01297464,"threshold_uncertainty_score":0.02579826,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3168701893","doi":"10.1007/s41669-021-00275-6","title":"Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto; University Health Network","funders":"Addis Ababa University","keywords":"Dolutegravir; Efavirenz; Human immunodeficiency virus (HIV); Medicine; Virology; Tenofovir; Second line; Pediatrics; Antiretroviral therapy; First line; Internal medicine; Viral load","authors":[{"name":"Yared Belete Belay","is_ca":false},{"name":"Eskinder Eshetu Ali","is_ca":false},{"name":"Karen Y. Chung","is_ca":true},{"name":"Gebremedhin Beedemariam Gebretekle","is_ca":true},{"name":"Beate Sander","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05826420296885351,"gpt":0.3741730334568439,"spread":0.3159088304879903,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005582214,0.001098494,0.001580078,0.0011734,0.0002666385,0.001531241,0.00105248,0.0009598735,0.003368509],"category_scores_gemma":[0.009401938,0.0005542382,0.003068878,0.0008408356,0.0004506557,0.0008348798,0.0009585246,0.001107246,0.0001151723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006080299,"about_ca_system_score_gemma":0.003091116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01298932,"about_ca_topic_score_gemma":0.006545526,"domain_scores_codex":[0.9981091,0.001444161,0.00005459805,0.0001118619,0.0001044611,0.0001757988],"domain_scores_gemma":[0.9935498,0.005442946,0.0004476095,0.00009220451,0.0002218966,0.0002457286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.00401955,0.0004108834,0.01217669,0.0005169823,0.001326144,0.000366992,0.00003891964,0.9697234,0.0004839373,0.002170813,0.0004288804,0.008336671],"study_design_scores_gemma":[0.001401369,0.003844264,0.01445352,0.0004461913,0.002174162,0.0004609181,0.0003027307,0.9722289,0.001243249,0.002387861,0.0009777243,0.00007901887],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782549,0.005357682,0.009226256,0.0009943544,0.00006656964,0.0005489825,0.00169809,0.0000416817,0.003811568],"genre_scores_gemma":[0.9962381,0.0006428979,0.002212603,0.00008683683,0.000009647653,0.00009313239,0.00025342,0.000005119058,0.0004582264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01298932,"threshold_uncertainty_score":0.04411584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3125780982","doi":"10.1007/s41669-020-00244-5","title":"An Exploration on Attribute Non-attendance Using Discrete Choice Experiment Data from the Irish EQ-5D-5L National Valuation Study","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health Research Institute; Simon Fraser University; Vancouver Coastal Health","funders":"Health Research Board","keywords":"Valuation (finance); EQ-5D; Attendance; Irish; Latent class model; Discrete choice; Actuarial science; Quality-adjusted life year; Health care; Psychology; Econometrics; Medicine; Computer science; Health related quality of life; Economics; Machine learning; Cost effectiveness; Risk analysis (engineering); Disease","authors":[{"name":"Edel Doherty","is_ca":true},{"name":"Anna Hobbins","is_ca":false},{"name":"David G. T. Whitehurst","is_ca":true},{"name":"Ciarán O’Neill","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.8063207396074529,"gpt":0.5751746631831023,"spread":0.2311460764243506,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1301246,0.0005857445,0.000980876,0.0005560934,0.0007114832,0.001964373,0.001304307,0.001109332,0.003445316],"category_scores_gemma":[0.1781579,0.0003391047,0.001999821,0.001181824,0.002644699,0.002223588,0.002071953,0.002654574,0.0003279824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002083721,"about_ca_system_score_gemma":0.001957743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003873056,"about_ca_topic_score_gemma":0.003603764,"domain_scores_codex":[0.8936492,0.098674,0.001841074,0.001870971,0.003075832,0.000888848],"domain_scores_gemma":[0.5171494,0.4516358,0.009947545,0.01684189,0.003864436,0.0005609046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02445103,0.02181632,0.5128828,0.003003178,0.002479148,0.0008402481,0.03982963,0.04066079,0.003922221,0.1011476,0.006173674,0.2427934],"study_design_scores_gemma":[0.00479721,0.03317138,0.5175555,0.002058509,0.00230384,0.0006975374,0.02924804,0.2246904,0.01203864,0.1388385,0.03367416,0.0009262804],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9607864,0.0002808473,0.03160225,0.000773279,0.00004898627,0.001364834,0.0009674199,0.00002399495,0.00415198],"genre_scores_gemma":[0.9727966,0.000148862,0.02200664,0.0004182328,0.00002871832,0.002797654,0.0009772603,0.0000146456,0.0008114631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1301246,"threshold_uncertainty_score":0.6881726,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3097148862","doi":"10.1007/s41669-020-00235-6","title":"Investigation of Factors Considered by Health Technology Assessment Agencies in Eight Countries","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Pharmacoeconomics; Health technology; Excellence; Economic evaluation; Nice; Medicine; Health economics; Health care; Stakeholder; Transparency (behavior); Family medicine; Economic growth; Political science; Public relations; Economics; Intensive care medicine","authors":[{"name":"Akira Yuasa","is_ca":false},{"name":"Naohiro Yonemoto","is_ca":false},{"name":"Sven Demiya","is_ca":false},{"name":"Chihiro Foellscher","is_ca":false},{"name":"Shunya Ikeda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5166002091916603,"gpt":0.5059722978757282,"spread":0.0106279113159321,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0676342,0.0004431219,0.0006863801,0.008050374,0.003005166,0.008444929,0.001092182,0.001575276,0.002505338],"category_scores_gemma":[0.1826535,0.0004685042,0.001531351,0.01306168,0.002561802,0.002929864,0.004313186,0.001761329,0.000176558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01746432,"about_ca_system_score_gemma":0.01338246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01626943,"about_ca_topic_score_gemma":0.007984175,"domain_scores_codex":[0.9015221,0.06199946,0.01491928,0.002569078,0.01323251,0.005757581],"domain_scores_gemma":[0.6415209,0.2335973,0.06972513,0.005216077,0.04344182,0.006498785],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001079989,0.0003907882,0.8579627,0.002557779,0.0007340806,0.001009014,0.03215067,0.002816247,0.0005065654,0.01001904,0.003318917,0.08745423],"study_design_scores_gemma":[0.0001829973,0.001101191,0.826179,0.003086546,0.0006614585,0.0008309876,0.1287567,0.003417376,0.001258238,0.002949849,0.03137347,0.0002021994],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9675149,0.003930465,0.001269524,0.006509496,0.00005753212,0.0006648456,0.00103854,0.00002725014,0.01898726],"genre_scores_gemma":[0.9976459,0.0005694691,0.0008854563,0.0004050133,0.00001448944,0.000140806,0.0001543228,0.000005247623,0.000179232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9323658,"threshold_uncertainty_score":0.3576881,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388790771","doi":"10.1007/s41669-023-00453-8","title":"Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Confidence interval; Incidence (geometry); Intensive care unit; Pediatrics; Emergency medicine; Diagnosis code; Internal medicine; Population","authors":[{"name":"Hilary M. DuBrock","is_ca":false},{"name":"Hayley D. Germack","is_ca":false},{"name":"Marjolaine Gauthier‐Loiselle","is_ca":true},{"name":"Jörg Linder","is_ca":false},{"name":"Ambika Satija","is_ca":false},{"name":"Ameur M. Manceur","is_ca":true},{"name":"Martin Cloutier","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Sumeet Panjabi","is_ca":false},{"name":"Robert P. Frantz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03449138985864929,"gpt":0.3230252596315598,"spread":0.2885338697729105,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001181896,0.000183279,0.0003307958,0.0007683804,0.0002769925,0.0009196448,0.0004230302,0.0004464947,0.001932947],"category_scores_gemma":[0.007920889,0.0001605798,0.0007750213,0.001201524,0.0002677415,0.0005346867,0.0009209162,0.001073027,0.0001173237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001723045,"about_ca_system_score_gemma":0.001169314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01828615,"about_ca_topic_score_gemma":0.01719265,"domain_scores_codex":[0.9985189,0.000662106,0.0001668687,0.0001320062,0.0002379003,0.000282236],"domain_scores_gemma":[0.9940259,0.001363383,0.003466256,0.00010974,0.0004088083,0.0006258444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001721658,0.00004919812,0.9926674,0.00007420453,0.000212566,0.0001481464,0.00003928177,0.0007945742,0.00003172413,0.0002371788,0.001035693,0.004537947],"study_design_scores_gemma":[0.0000373261,0.0001385779,0.9930189,0.0001812532,0.0001315047,0.0006651466,0.0004687813,0.00368375,0.00005247774,0.0003892058,0.001220462,0.00001254657],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882801,0.00398742,0.0002387543,0.002820248,0.00007120227,0.00002057801,0.003450538,0.000004759013,0.001126486],"genre_scores_gemma":[0.997656,0.0008879324,0.0001164434,0.0001569732,0.00005648201,0.00001046533,0.001043814,0.000001265274,0.00007051362],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01828615,"threshold_uncertainty_score":0.03635949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2954548710","doi":"10.1007/s41669-019-0156-x","title":"The Use of Computer Simulation Modeling to Estimate Complications in Patients with Type 2 Diabetes Mellitus: Comparative Validation of the Cornerstone Diabetes Simulation Model","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; Diabetes mellitus; Absolute risk reduction; United Kingdom Prospective Diabetes Study; Type 2 diabetes; Clinical trial; Confidence interval; Internal medicine","authors":[{"name":"Zhuo T. Su","is_ca":false},{"name":"José Bartelt-Hofer","is_ca":false},{"name":"Stephen Brown","is_ca":false},{"name":"Elisheva Lew","is_ca":false},{"name":"Luc Sauriol","is_ca":true},{"name":"Lieven Annemans","is_ca":false},{"name":"Daniel Grima","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0777691001279494,"gpt":0.3536708675563976,"spread":0.2759017674284482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01237924,0.0008214004,0.001101271,0.001067257,0.0002857184,0.001459748,0.001261115,0.001214983,0.0009662736],"category_scores_gemma":[0.05071859,0.0005792944,0.001183574,0.0008906485,0.0004674931,0.0007185808,0.0009397271,0.001105665,0.0001566991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001556269,"about_ca_system_score_gemma":0.002452582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02106458,"about_ca_topic_score_gemma":0.005754872,"domain_scores_codex":[0.9933817,0.005267637,0.0003515647,0.0003793884,0.0004679253,0.0001517884],"domain_scores_gemma":[0.9218001,0.07004724,0.002018176,0.002729887,0.002923673,0.0004809373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001115021,0.000199339,0.02473508,0.0001143129,0.0002788691,0.00006661045,0.0001672164,0.9569686,0.0003567167,0.001597592,0.0003384514,0.01406222],"study_design_scores_gemma":[0.0001552493,0.0003146271,0.003356474,0.00005119491,0.00006022842,0.00003478196,0.0000464962,0.9943181,0.0003908912,0.0009058199,0.0003415851,0.00002459049],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8665475,0.0008218539,0.1248807,0.000799881,0.0001133047,0.0004912669,0.001138414,0.0005331737,0.004673901],"genre_scores_gemma":[0.9758586,0.0002636949,0.02269198,0.0001141193,0.00001416005,0.0002277413,0.0005632409,0.00003181398,0.0002345931],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02106458,"threshold_uncertainty_score":0.06546849,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4360601194","doi":"10.1007/s41669-023-00406-1","title":"Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Novartis","keywords":"Purchasing; Discounting; Health care; Thematic analysis; Value-Based Purchasing; Business; Reimbursement; Actuarial science; Public economics; Marketing; Economics; Qualitative research; Economic growth; Finance","authors":[{"name":"Mackenzie Mills","is_ca":false},{"name":"Panos Kanavos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5573958734861583,"gpt":0.5653476281504209,"spread":0.007951754664262678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04242671,0.0003026885,0.0005754678,0.004010366,0.0008937901,0.005677338,0.0009802935,0.0009814505,0.003095047],"category_scores_gemma":[0.09128501,0.0002593214,0.001143029,0.008053069,0.002403597,0.002666516,0.003318918,0.001224506,0.0001681091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009149573,"about_ca_system_score_gemma":0.008863912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04126913,"about_ca_topic_score_gemma":0.0258888,"domain_scores_codex":[0.97101,0.01730322,0.00391948,0.0008449537,0.005341405,0.001580877],"domain_scores_gemma":[0.8231201,0.120444,0.03435641,0.002966312,0.01675683,0.002356327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0017204,0.000297918,0.6314698,0.01792867,0.00106265,0.001915921,0.04988027,0.001054379,0.0002227907,0.01216012,0.01138809,0.2708991],"study_design_scores_gemma":[0.0001966201,0.0004707105,0.7592067,0.03379248,0.001243455,0.001230077,0.1243099,0.0005248819,0.0005612999,0.001376876,0.07696295,0.0001239881],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8076895,0.1263472,0.0007221541,0.01639189,0.0002886473,0.0002282904,0.00185462,0.00002011572,0.04645761],"genre_scores_gemma":[0.96051,0.03578278,0.0005040627,0.0023621,0.00006554044,0.00007225046,0.0004223487,0.00001118211,0.0002698182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04242671,"threshold_uncertainty_score":0.2243766,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3016073506","doi":"10.1007/s41669-020-00215-w","title":"Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder","year":2020,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health","funders":"Astellas Pharma Global Development; Astellas Pharma","keywords":"Anticholinergic; Medicine; Cohort; Overactive bladder; Emergency medicine; Cohort study; Health care; Anticholinergic agents; Physical therapy; Internal medicine; Alternative medicine","authors":[{"name":"Greta Lozano‐Ortega","is_ca":true},{"name":"Carol R. Schermer","is_ca":false},{"name":"David Walker","is_ca":false},{"name":"Shelagh M. Szabo","is_ca":true},{"name":"Basia Rogula","is_ca":true},{"name":"Alison Deighton","is_ca":true},{"name":"Katherine Gooch","is_ca":false},{"name":"Noll L. Campbell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03060497513465011,"gpt":0.3536645339930266,"spread":0.3230595588583764,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008570877,0.0002724992,0.000379836,0.001392965,0.0003823081,0.0006731267,0.0004590588,0.0004717134,0.001858065],"category_scores_gemma":[0.004950658,0.0002819179,0.001280002,0.001856819,0.0001860509,0.0005931844,0.000781772,0.0007890493,0.0001714739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006152801,"about_ca_system_score_gemma":0.0004531565,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0183922,"about_ca_topic_score_gemma":0.01990712,"domain_scores_codex":[0.9994185,0.0001387387,0.0001164514,0.00007416939,0.0001350953,0.0001171104],"domain_scores_gemma":[0.9972326,0.0004355497,0.001614009,0.00009592266,0.000327786,0.0002941749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004335301,0.00001625645,0.9991561,0.000009591004,0.00006133722,0.00001598158,0.00001800979,0.00006591596,0.000007978202,0.000009262672,0.00004815125,0.0005481432],"study_design_scores_gemma":[0.000002973435,0.0000251439,0.9994103,0.000009842342,0.0000273941,0.00006725463,0.00006664221,0.0003070445,0.000005853303,0.00002656721,0.00004898448,0.000002100896],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978991,0.0005710489,0.00005788094,0.0001169674,0.000005208077,0.00001142317,0.0009931873,0.000002119524,0.0003431341],"genre_scores_gemma":[0.9989856,0.0002335411,0.00008528159,0.00001860222,0.00001141005,0.00001199257,0.0005926848,8.757533e-7,0.00006000601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0183922,"threshold_uncertainty_score":0.03657031,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308254443","doi":"10.1007/s41669-022-00375-x","title":"A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"ABB (Canada); Foothills Medical Centre","funders":"AbbVie","keywords":"Obinutuzumab; Venetoclax; Medicine; Chlorambucil; Rituximab; Bendamustine; Internal medicine; Fludarabine; Chronic lymphocytic leukemia; Ibrutinib; Oncology; Population; Ofatumumab; Cyclophosphamide; Leukemia; Chemotherapy; Lymphoma","authors":[{"name":"Anuja Chatterjee","is_ca":false},{"name":"Gijs van de Wetering","is_ca":false},{"name":"Ron Goeree","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Anne Marie Desbois","is_ca":true},{"name":"Stéphane Barakat","is_ca":true},{"name":"Beenish S. Manzoor","is_ca":false},{"name":"Kavita Sail","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04922340262774139,"gpt":0.3689317120683685,"spread":0.3197083094406271,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004650886,0.001602031,0.001859296,0.001636805,0.00102297,0.002501501,0.002788812,0.001864893,0.004978959],"category_scores_gemma":[0.01278839,0.001052964,0.002857338,0.002023801,0.001213031,0.0008750095,0.001260378,0.00202081,0.0001771938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04434488,"about_ca_system_score_gemma":0.02427574,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8094695,"about_ca_topic_score_gemma":0.605514,"domain_scores_codex":[0.9977672,0.00111215,0.00005525137,0.0002068017,0.0002442641,0.0006141916],"domain_scores_gemma":[0.9916527,0.005813873,0.0006572704,0.0001522222,0.00103106,0.0006928768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001097667,0.0001120113,0.00402315,0.0001597471,0.0002891443,0.000164362,0.00004067596,0.9851151,0.0001267612,0.004556266,0.001115313,0.003199698],"study_design_scores_gemma":[0.0007796027,0.0005722719,0.007774225,0.0001336612,0.0007296178,0.000107636,0.0002039095,0.9845827,0.0001792095,0.00275281,0.002118879,0.00006544513],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9360598,0.00634884,0.01259506,0.004386454,0.0000941679,0.001587059,0.01639446,0.0001292111,0.02240487],"genre_scores_gemma":[0.9917318,0.001073095,0.002328823,0.0002035656,0.00001756531,0.0002495851,0.00191284,0.00001226754,0.002470415],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1905305,"threshold_uncertainty_score":0.3833051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2755337532","doi":"10.1007/s41669-017-0057-9","title":"Out-of-Pocket Expenditures, Indirect Costs and Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Thailand","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"","keywords":"Medicine; Health care; Pharmacist; Tuberculosis; Indirect costs; Family medicine; Pulmonary tuberculosis; Total cost; Emergency medicine; Pharmacy","authors":[{"name":"Pimwara Tanvejsilp","is_ca":true},{"name":"Mark Loeb","is_ca":true},{"name":"Jonathan Dushoff","is_ca":true},{"name":"Feng Xie","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1015451370450879,"gpt":0.4188376856994597,"spread":0.3172925486543717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004857372,0.0002362851,0.0002355011,0.0005651259,0.0003810388,0.0008774106,0.0002438842,0.0002793177,0.001362989],"category_scores_gemma":[0.002089435,0.0001944257,0.0003930885,0.001309503,0.0002829487,0.0005251707,0.000581722,0.0006336467,0.0001149663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006344897,"about_ca_system_score_gemma":0.000509388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01046698,"about_ca_topic_score_gemma":0.01053491,"domain_scores_codex":[0.9995004,0.0001880761,0.0000948924,0.000058636,0.00006707269,0.00009098904],"domain_scores_gemma":[0.9977663,0.0003519501,0.001361856,0.00005011029,0.0001451389,0.0003247018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006589969,0.00003640034,0.9983931,0.00002040862,0.00003062841,0.00008723165,0.0001360304,0.00008929774,0.00002675991,0.00001046319,0.000074999,0.001028751],"study_design_scores_gemma":[0.000006456361,0.00008689812,0.9982893,0.00001916408,0.00001869172,0.0002680505,0.0008380354,0.000308398,0.00002223146,0.00002529603,0.0001127944,0.000004646996],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999184,0.0001833755,0.00002259059,0.00004892535,0.000001655785,0.000003884641,0.0003295325,6.770823e-7,0.0002253876],"genre_scores_gemma":[0.9995253,0.0001322255,0.0000309828,0.00001521067,0.000003146695,0.000007517787,0.0002255209,4.777145e-7,0.00005974251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01046698,"threshold_uncertainty_score":0.02081209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3154274729","doi":"10.1007/s41669-021-00263-w","title":"Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"","keywords":"Medicine; MEDLINE; Economic evaluation; Oncology; Family medicine; Internal medicine; Medical physics; Pathology","authors":[{"name":"Graeme Ball","is_ca":true},{"name":"Mitchell Levine","is_ca":true},{"name":"Lehana Thabane","is_ca":true},{"name":"Jean‐Éric Tarride","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.670614332465464,"gpt":0.6442023617784887,"spread":0.02641197068697532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3126731,0.001890355,0.007186534,0.02536771,0.001713012,0.0103852,0.002307225,0.002749763,0.004189628],"category_scores_gemma":[0.6413974,0.002183332,0.009671258,0.02466943,0.003808894,0.01267041,0.006400476,0.005040292,0.0004514128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01346775,"about_ca_system_score_gemma":0.02812042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007762666,"about_ca_topic_score_gemma":0.01343333,"domain_scores_codex":[0.5836626,0.2452006,0.1178297,0.007139615,0.04427178,0.001895654],"domain_scores_gemma":[0.2763184,0.6090941,0.06163341,0.00969538,0.04139173,0.001867001],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001083074,0.00009217023,0.01046977,0.5413224,0.00981506,0.0001633094,0.006228737,0.0006853434,0.0003110971,0.007030349,0.008781744,0.4140169],"study_design_scores_gemma":[0.0004491822,0.0004337229,0.01193336,0.9218006,0.008368604,0.0003818163,0.002907864,0.0005219646,0.0002856015,0.005484039,0.04730437,0.0001288208],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.009245648,0.9665246,0.006343194,0.00848858,0.0007107675,0.003148107,0.001639276,0.00005240569,0.003847519],"genre_scores_gemma":[0.105473,0.8493099,0.02449805,0.008381736,0.0005504433,0.009885898,0.001238508,0.0001370589,0.0005253177],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6873269,"threshold_uncertainty_score":0.8475965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2581612511","doi":"10.1007/s41669-017-0011-x","title":"Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Astellas Pharma Global Development; Astellas Pharma Europe; Astellas Pharma; Canadian Urological Association; Duchesnay; Pfizer","keywords":"Mirabegron; Tolterodine; Overactive bladder; Oxybutynin; Solifenacin; Medicine; Urology; Cohort; Internal medicine","authors":[{"name":"Jameel Nazir","is_ca":false},{"name":"Malin Berling","is_ca":false},{"name":"Charles McCrea","is_ca":false},{"name":"Francis Fatoye","is_ca":false},{"name":"Sally Bowditch","is_ca":false},{"name":"Zalmaï Hakimi","is_ca":false},{"name":"Adrian Wagg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1589304446283486,"gpt":0.5192326041491452,"spread":0.3603021595207966,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003493066,0.0007244974,0.001014336,0.0007898114,0.000277699,0.002109411,0.0007759535,0.001479639,0.003225547],"category_scores_gemma":[0.0145793,0.0005647347,0.002242274,0.0008604451,0.0006053434,0.0015105,0.001213076,0.00112625,0.0001833335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01008365,"about_ca_system_score_gemma":0.002332295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05862328,"about_ca_topic_score_gemma":0.02874808,"domain_scores_codex":[0.9963706,0.002558764,0.0001534096,0.0002394092,0.0002734045,0.0004043845],"domain_scores_gemma":[0.9943124,0.003787337,0.001046538,0.00009844232,0.0004115303,0.00034378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.008148471,0.0002997532,0.07993913,0.001820294,0.002459303,0.001674702,0.0002037374,0.8699391,0.0007301505,0.008522703,0.004127308,0.02213529],"study_design_scores_gemma":[0.003407884,0.007241469,0.1375268,0.002359584,0.003529604,0.002417868,0.001313835,0.8211525,0.001424516,0.009843788,0.009500364,0.0002818944],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9611485,0.01525127,0.004243919,0.004539654,0.0001965779,0.0002810762,0.005128051,0.0000396507,0.009171268],"genre_scores_gemma":[0.997543,0.001030375,0.0003333242,0.000193401,0.00001032306,0.00003238832,0.0004059115,0.000004267491,0.0004471312],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05862328,"threshold_uncertainty_score":0.1165641,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4225004644","doi":"10.1007/s41669-022-00331-9","title":"Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; Population Health Research Institute; Takeda (Canada)","funders":"","keywords":"Vedolizumab; Medicine; Tofacitinib; Golimumab; Ustekinumab; Ulcerative colitis; Infliximab; Adalimumab; Internal medicine; Disease","authors":[{"name":"Elisabetta Fenu","is_ca":false},{"name":"Vasily Lukyanov","is_ca":false},{"name":"Annabel Acs","is_ca":false},{"name":"Xenia Radu","is_ca":false},{"name":"Stephanie Stypa","is_ca":true},{"name":"Aren Fischer","is_ca":true},{"name":"John K. Marshall","is_ca":true},{"name":"Mark Oppe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.023059148200213,"gpt":0.3108708866433255,"spread":0.2878117384431125,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001701066,0.0004280601,0.0005426477,0.0008674245,0.0008390913,0.001462125,0.001103743,0.000516906,0.002330865],"category_scores_gemma":[0.007009193,0.0003494619,0.001159708,0.001253217,0.0005250176,0.000424339,0.0006929084,0.000825004,0.00007328922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06317417,"about_ca_system_score_gemma":0.05149329,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9721979,"about_ca_topic_score_gemma":0.9654682,"domain_scores_codex":[0.998751,0.0003747215,0.00004922636,0.0000978465,0.0003590331,0.0003681061],"domain_scores_gemma":[0.9972243,0.001046277,0.0004721786,0.00005310966,0.0006736233,0.0005305086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.009610333,0.0008152936,0.3498671,0.0009335726,0.0020884,0.0008016233,0.000397558,0.5068153,0.001455394,0.0111517,0.009134454,0.1069292],"study_design_scores_gemma":[0.001513681,0.001404726,0.206935,0.0004095266,0.001593111,0.0004012764,0.0008668521,0.778042,0.0008552843,0.002646566,0.005208165,0.0001238405],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763206,0.005009137,0.00204913,0.002962229,0.00003057141,0.0003019426,0.004364277,0.00006234836,0.008899805],"genre_scores_gemma":[0.9971486,0.0007965635,0.000745156,0.0001006622,0.000005187121,0.00002439172,0.0006942939,0.000005031429,0.0004799616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06317417,"threshold_uncertainty_score":0.4583629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766103705","doi":"10.1007/s41669-018-0112-1","title":"Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Bristol-Myers Squibb (Canada); McGill University","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Ipilimumab; Nivolumab; Medicine; Pembrolizumab; Regimen; Internal medicine; Oncology; Progression-free survival; Cost effectiveness; Immunotherapy; Cancer; Chemotherapy","authors":[{"name":"Peter Quon","is_ca":false},{"name":"Ying Xiao","is_ca":false},{"name":"Sonja Sorensen","is_ca":false},{"name":"Amir Abbas Tahami Monfared","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02394847874053593,"gpt":0.3310521936035749,"spread":0.3071037148630389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002997006,0.001069847,0.0010982,0.00121393,0.000931222,0.002111476,0.001394508,0.0009284862,0.003034807],"category_scores_gemma":[0.008978849,0.0004583153,0.001727002,0.001813081,0.0006920106,0.0005757004,0.0009521654,0.001266951,0.0001043299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08331508,"about_ca_system_score_gemma":0.06650522,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9235267,"about_ca_topic_score_gemma":0.908836,"domain_scores_codex":[0.9980323,0.001014857,0.00006266383,0.0001099581,0.0003501139,0.0004300727],"domain_scores_gemma":[0.9967545,0.001352367,0.0003499015,0.00005904746,0.000952607,0.000531527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01025602,0.00108546,0.05043305,0.002579409,0.003399335,0.0006445203,0.0001569908,0.8739789,0.0008397868,0.009136858,0.007369166,0.04012052],"study_design_scores_gemma":[0.005542472,0.003231251,0.04838433,0.0009891841,0.003820653,0.0003696038,0.0007931432,0.9216709,0.001052306,0.003005203,0.01098393,0.0001571183],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9252044,0.02120248,0.004682962,0.006718825,0.0001973534,0.00195745,0.01074155,0.00009973816,0.02919527],"genre_scores_gemma":[0.9939322,0.00197612,0.001405257,0.0002389584,0.0000160547,0.0001171611,0.001165244,0.000007045072,0.001142021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08331508,"threshold_uncertainty_score":0.6044961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2617296499","doi":"10.1007/s41669-017-0030-7","title":"Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Programs for Assessment of Technology in Health Research Institute; Impact","funders":"","keywords":"Bevacizumab; Ovarian cancer; Medicine; Oncology; Internal medicine; Cancer; Chemotherapy","authors":[{"name":"Graeme Ball","is_ca":true},{"name":"Feng Xie","is_ca":true},{"name":"Jean-Eric Tarride","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1083930942929834,"gpt":0.4342703966696648,"spread":0.3258773023766814,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005330781,0.0009677081,0.001003146,0.0017884,0.001152587,0.002297049,0.00173565,0.0009871442,0.003878116],"category_scores_gemma":[0.01859774,0.0004779887,0.002074484,0.002457167,0.0008084745,0.0006761527,0.001183739,0.001397083,0.0001204574],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1129932,"about_ca_system_score_gemma":0.1044099,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9516772,"about_ca_topic_score_gemma":0.9362279,"domain_scores_codex":[0.9964833,0.00177574,0.0001175722,0.0001665352,0.0008731245,0.0005836723],"domain_scores_gemma":[0.9943112,0.002635347,0.0005242603,0.0001097712,0.001796762,0.0006225525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.006805247,0.0006305318,0.0296685,0.001904941,0.002179509,0.0005506502,0.0002414388,0.8749014,0.0006802548,0.01893583,0.009626389,0.05387539],"study_design_scores_gemma":[0.003249347,0.001961158,0.03447291,0.0008692148,0.002209378,0.0003080711,0.0007523166,0.9336786,0.000715574,0.006669918,0.0149299,0.0001836269],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8763939,0.02068416,0.01275233,0.01062705,0.0002614912,0.004494341,0.01760128,0.0001698749,0.05701563],"genre_scores_gemma":[0.9894938,0.002369325,0.003595027,0.0004000877,0.0000199537,0.0003697045,0.002016044,0.00001807713,0.001717869],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1129932,"threshold_uncertainty_score":0.8198271,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405460373","doi":"10.1007/s41669-024-00537-z","title":"Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations","year":2024,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"F. Hoffmann-La Roche; Roche","keywords":"Resource (disambiguation); Management science; Psychological intervention; Health care; Health technology; Set (abstract data type); Risk analysis (engineering); Economic evaluation; Computer science; Intervention (counseling); Knowledge management; Process management; Environmental economics; Business; Medicine; Economics; Nursing; Microeconomics","authors":[{"name":"Praveen Thokala","is_ca":false},{"name":"Henrique Duarte","is_ca":false},{"name":"Stuart Wright","is_ca":false},{"name":"Don Husereau","is_ca":true},{"name":"Isabelle Durand‐Zaleski","is_ca":false},{"name":"Peter Lindgren","is_ca":false},{"name":"Roelien Postema","is_ca":false},{"name":"Gerardo Machnicki","is_ca":false},{"name":"Louis P. Garrison","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7165022102291071,"gpt":0.6053250367160649,"spread":0.1111771735130422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4695537,0.004899994,0.007381542,0.01312406,0.002420467,0.01749643,0.006608133,0.008045192,0.002786326],"category_scores_gemma":[0.614051,0.003851547,0.008860871,0.01802712,0.01077903,0.01559722,0.01015517,0.01401307,0.0004638364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01519199,"about_ca_system_score_gemma":0.0251594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009829224,"about_ca_topic_score_gemma":0.009153218,"domain_scores_codex":[0.3408905,0.5969359,0.03705871,0.004387803,0.01870708,0.002020014],"domain_scores_gemma":[0.2011151,0.7553173,0.01748336,0.009768473,0.01558347,0.0007323379],"domain_codex":"methods","domain_gemma":"methods","domain_candidate":"methods","domain_consensus":"methods","study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0004315588,0.0003292603,0.004591469,0.02380155,0.003768658,0.000433284,0.001939601,0.07534911,0.0002523564,0.6896166,0.005078599,0.194408],"study_design_scores_gemma":[0.0005549395,0.0004877017,0.002106707,0.04730741,0.002234223,0.0003868472,0.001341843,0.09108765,0.001344438,0.8007444,0.05197081,0.0004330438],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.002588947,0.08091788,0.882251,0.0177941,0.0007263731,0.007131643,0.0003711401,0.0001267503,0.00809213],"genre_scores_gemma":[0.08472759,0.04367812,0.8456317,0.004375158,0.00103144,0.01945616,0.0002464358,0.0001330736,0.0007203149],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.5304463,"threshold_uncertainty_score":0.6541348,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4366351945","doi":"10.1007/s41669-023-00407-0","title":"Healthcare Resource Utilization and Costs in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer Receiving First-Line Treatment in the United States: An Insurance Claims-Based Descriptive Analysis","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Osimertinib; Medicine; Lung cancer; Health care; Population; Oncology; Disease; Internal medicine; Chemotherapy; Cancer; Intensive care medicine; Epidermal growth factor receptor; Erlotinib; Environmental health","authors":[{"name":"Julie Vanderpoel","is_ca":false},{"name":"Bruno Émond","is_ca":true},{"name":"Isabelle Ghelerter","is_ca":true},{"name":"Katherine Milbers","is_ca":true},{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Lorie Ellis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04130728605065252,"gpt":0.3808028667329686,"spread":0.3394955806823161,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009285215,0.0002876433,0.0004472798,0.00305554,0.000344292,0.0008970346,0.0006361685,0.0004560735,0.00140502],"category_scores_gemma":[0.003655336,0.0002780455,0.001123662,0.00455388,0.0002575058,0.0008456498,0.0008099118,0.0006792626,0.0002181293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001309366,"about_ca_system_score_gemma":0.0008700424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02802157,"about_ca_topic_score_gemma":0.02329652,"domain_scores_codex":[0.999077,0.0001804974,0.0002609231,0.0001581801,0.0002033862,0.0001200029],"domain_scores_gemma":[0.9959469,0.0008147579,0.002498498,0.0001325901,0.0003274078,0.00027976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009318892,0.00005500565,0.9979063,0.00003122715,0.0001386759,0.00003688269,0.00006013798,0.0002422301,0.00002551972,0.00004532272,0.0005634289,0.0008019931],"study_design_scores_gemma":[0.00001483422,0.00007730741,0.9973145,0.0000309348,0.00005512474,0.0001923279,0.0004660951,0.001338108,0.00003473314,0.00004874922,0.0004180989,0.000009071402],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837893,0.0004041883,0.00008355091,0.000123181,0.000005986587,0.00004326664,0.01493291,0.000008046727,0.0006096008],"genre_scores_gemma":[0.9883464,0.00029667,0.0001527986,0.00007568199,0.00001230072,0.0000782955,0.01090341,0.00000336794,0.0001311215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02802157,"threshold_uncertainty_score":0.05571693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323921312","doi":"10.1007/s41669-023-00400-7","title":"Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; University of Calgary; Alberta Health; University of Alberta; Institute of Health Economics","funders":"University of Alberta; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Alberta Health Services","keywords":"Randomized controlled trial; Medicine; COPD; Bundle; Emergency medicine; Internal medicine","authors":[{"name":"Charles Yan","is_ca":true},{"name":"Jeff Round","is_ca":true},{"name":"İlke Akpinar","is_ca":true},{"name":"Chantal E. Atwood","is_ca":true},{"name":"Lesly Deuchar","is_ca":true},{"name":"Mohit Bhutani","is_ca":false},{"name":"Richard Leigh","is_ca":true},{"name":"Michael K. Stickland","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04406145939402985,"gpt":0.3905816534093894,"spread":0.3465201940153596,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006622626,0.002511269,0.006144888,0.0009981185,0.0007241123,0.0018649,0.002093115,0.003243905,0.006596299],"category_scores_gemma":[0.01367341,0.0009085152,0.00779283,0.001002054,0.001589572,0.001668481,0.001098359,0.004094666,0.0003991585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005303746,"about_ca_system_score_gemma":0.004064635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01475319,"about_ca_topic_score_gemma":0.01143792,"domain_scores_codex":[0.9922193,0.005507437,0.0005163724,0.0006528415,0.0005244595,0.0005795768],"domain_scores_gemma":[0.9920719,0.003881224,0.001774987,0.0004107293,0.0006532929,0.001207801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9870837,0.002641982,0.0005598874,0.000914775,0.002671367,0.0000188673,0.00002766427,0.0004339983,0.0000901146,0.00008085936,0.0002500983,0.005226729],"study_design_scores_gemma":[0.9619777,0.0312031,0.001693306,0.0001822427,0.002678687,0.00001337726,0.00003134374,0.001756552,0.00006694277,0.0001938787,0.0001846531,0.00001824732],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.969135,0.009762931,0.001971222,0.00145386,0.001768011,0.01234157,0.001484473,0.0002509187,0.001831934],"genre_scores_gemma":[0.9793677,0.00283808,0.003006578,0.0008466344,0.0005946776,0.01128413,0.0008359944,0.00002497155,0.001201142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01475319,"threshold_uncertainty_score":0.03848153,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2925255986","doi":"10.1007/s41669-019-0153-0","title":"All-Male Panels and Gender Diversity of Issue Panels and Plenary Sessions at ISPOR Europe","year":2019,"lang":"en","type":"letter","venue":"PharmacoEconomics - Open","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Diversity (politics); Plenary session; Political science; Engineering ethics; Library science; Engineering; Computer science; Law","authors":[{"name":"Jacoline C. Bouvy","is_ca":false},{"name":"Michelle Mujoomdar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1358255975837082,"gpt":0.3684017683739486,"spread":0.2325761707902403,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01801782,0.0009661719,0.001268283,0.0009371119,0.02132028,0.01117628,0.002424767,0.09157787,0.03744964],"category_scores_gemma":[0.04000114,0.001514271,0.00133413,0.0008733664,0.003455709,0.005175744,0.004906989,0.04274865,0.006927499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009157531,"about_ca_system_score_gemma":0.01479535,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01368104,"about_ca_topic_score_gemma":0.03469898,"domain_scores_codex":[0.9832097,0.004010733,0.0007379137,0.001442689,0.003039965,0.007558866],"domain_scores_gemma":[0.9537765,0.01860509,0.001921586,0.0008029201,0.004192234,0.02070166],"domain_codex":null,"domain_gemma":"incentives","domain_candidate":"incentives","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0002252417,0.0001584501,0.003848003,0.00005854145,0.00002947492,0.004719969,0.001164602,0.00009945974,0.0007091976,0.01080681,0.9697823,0.008397928],"study_design_scores_gemma":[0.0003031646,0.000223939,0.01611309,0.000520974,0.00006943554,0.002933219,0.009984993,0.0008370164,0.001532907,0.009469857,0.9578553,0.000155929],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.005020265,0.000487183,0.0001966833,0.9597518,0.01004604,0.00005526938,0.00007250888,0.00002198848,0.02434826],"genre_scores_gemma":[0.03824366,0.0004040611,0.0001962476,0.8892406,0.01143476,0.0001414121,0.00004345031,0.0000623568,0.06023338],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.9819822,"threshold_uncertainty_score":0.1252815,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3010862135","doi":"10.1007/s41669-020-00204-z","title":"Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews","year":2020,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Bell (Canada)","funders":"Janssen Pharmaceuticals","keywords":"Medicine; Rituximab; Follicular lymphoma; Cost effectiveness; Obinutuzumab; Systematic review; MEDLINE; Quality-adjusted life year; Bendamustine; Oncology; Internal medicine; Lymphoma","authors":[{"name":"Neerav Monga","is_ca":true},{"name":"Jamie Garside","is_ca":false},{"name":"Joan Quigley","is_ca":false},{"name":"Peter O’Donovan","is_ca":false},{"name":"Christoph Tapprich","is_ca":false},{"name":"Loretta J. Nastoupil","is_ca":false},{"name":"Catherine Thiéblemont","is_ca":false},{"name":"Christina Loefgren","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3293607670708495,"gpt":0.4732217885049921,"spread":0.1438610214341426,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01660763,0.002016243,0.01163492,0.01401671,0.0004663886,0.003764285,0.001926257,0.002211639,0.004556438],"category_scores_gemma":[0.08774619,0.001595491,0.016257,0.01338235,0.0009014051,0.002449468,0.001505865,0.001993281,0.000258892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005886156,"about_ca_system_score_gemma":0.009470014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009145994,"about_ca_topic_score_gemma":0.02167674,"domain_scores_codex":[0.9796578,0.009254867,0.00705942,0.00105683,0.002542421,0.0004287807],"domain_scores_gemma":[0.9262833,0.0574201,0.01133929,0.0007354011,0.003878884,0.0003429785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0003126969,0.00001766681,0.0007222611,0.9462764,0.02998262,0.00005276755,0.00007417383,0.000261351,0.00006133695,0.0002518842,0.001079652,0.02090711],"study_design_scores_gemma":[0.0007361627,0.000301213,0.005407864,0.7825733,0.1964544,0.0003723389,0.0002206874,0.0003068474,0.0001644462,0.0007669572,0.01263706,0.00005878275],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009717442,0.9974433,0.0001455646,0.0002464135,0.00009346291,0.0002726581,0.0005794225,0.00000883461,0.0002385348],"genre_scores_gemma":[0.03066728,0.9658124,0.001246369,0.0005917129,0.0001384847,0.001028819,0.000389924,0.00001285773,0.0001120837],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01660763,"threshold_uncertainty_score":0.0878306,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2975748077","doi":"10.1007/s41669-019-00180-z","title":"Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Azacitidine; Medicine; Myeloid leukemia; Cost effectiveness; Internal medicine; Oncology; Cytarabine; Population; Hypomethylating agent; Environmental health; DNA methylation","authors":[{"name":"Doug Coyle","is_ca":true},{"name":"Pierre Villeneuve","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02051727135984825,"gpt":0.3295631370827624,"spread":0.3090458657229141,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004209857,0.0008737086,0.001327003,0.0008524173,0.0004825679,0.001678869,0.001031483,0.001352362,0.00371268],"category_scores_gemma":[0.0128764,0.0005935998,0.002248484,0.0009580334,0.000586955,0.0008666959,0.0007906137,0.001579556,0.0001364807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01050011,"about_ca_system_score_gemma":0.008284963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.08067029,"about_ca_topic_score_gemma":0.04638056,"domain_scores_codex":[0.998271,0.001194811,0.00005247234,0.00009907837,0.0001621785,0.0002203868],"domain_scores_gemma":[0.995188,0.003689918,0.0004105399,0.00007299011,0.0002856646,0.0003528496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.004293531,0.0003706985,0.0204085,0.000720158,0.00116638,0.0004765893,0.00006370877,0.9486625,0.0004048268,0.006771862,0.001704616,0.01495663],"study_design_scores_gemma":[0.001423719,0.002143719,0.01760701,0.0004807603,0.001703126,0.0003328403,0.0002305462,0.9667831,0.0004677423,0.005540993,0.003218731,0.00006775092],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9376123,0.01191466,0.01860359,0.004304462,0.0001847447,0.00149609,0.0051585,0.00006850316,0.02065717],"genre_scores_gemma":[0.9953733,0.001169765,0.001827751,0.0001387358,0.0000192546,0.0001271283,0.0006563645,0.000004614438,0.0006831665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08067029,"threshold_uncertainty_score":0.1604015,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2609661473","doi":"10.1007/s41669-017-0022-7","title":"Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Toronto Public Health; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Tufts Medical Center","keywords":"Medicine; Oncology; Internal medicine","authors":[{"name":"Kavisha Jayasundara","is_ca":true},{"name":"Murray Krahn","is_ca":true},{"name":"Muhammad Mamdani","is_ca":true},{"name":"Jeffrey S. Hoch","is_ca":true},{"name":"Paul Grootendorst","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6709276885782226,"gpt":0.5865158343262132,"spread":0.08441185425200937,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03437967,0.000459175,0.001382647,0.0044929,0.0008080697,0.00270076,0.001066814,0.002022925,0.003771309],"category_scores_gemma":[0.1484366,0.0003705183,0.003334531,0.004418504,0.001675188,0.003556628,0.001980603,0.00323933,0.0002403586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00287357,"about_ca_system_score_gemma":0.001237619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005181856,"about_ca_topic_score_gemma":0.005852055,"domain_scores_codex":[0.9741288,0.01643167,0.002979135,0.001988279,0.003240659,0.001231302],"domain_scores_gemma":[0.7793737,0.192653,0.01605251,0.005488999,0.004813167,0.001618768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002978122,0.0002113199,0.8442892,0.001829192,0.00329435,0.00977901,0.001596339,0.004398503,0.0008681078,0.01999025,0.006062387,0.1047032],"study_design_scores_gemma":[0.00066825,0.001190682,0.8252964,0.003884851,0.00789106,0.04168015,0.00875782,0.02364434,0.001839744,0.06748883,0.01725962,0.0003981917],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8903784,0.0533627,0.008284687,0.03004345,0.0002423445,0.0002933828,0.001390617,0.00004331757,0.01596115],"genre_scores_gemma":[0.9943215,0.002509099,0.001777439,0.0009102755,0.0001358437,0.00004642692,0.0001879837,0.00001236019,0.00009908454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03437967,"threshold_uncertainty_score":0.1818193,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2748882349","doi":"10.1007/s41669-017-0053-0","title":"Healthcare Resource Uses and Out-of-Pocket Expenses Associated with Pulmonary TB Treatment in Thailand","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"","keywords":"Medicine; Confidence interval; Health care; Pharmaceutical care; Pulmonary tuberculosis; Public health; Retrospective cohort study; Tuberculosis; Family medicine; Emergency medicine; Internal medicine; Nursing; Pharmacy","authors":[{"name":"Pimwara Tanvejsilp","is_ca":true},{"name":"Mark Loeb","is_ca":true},{"name":"Jonathan Dushoff","is_ca":true},{"name":"Feng Xie","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1341411480989907,"gpt":0.4376703003657257,"spread":0.303529152266735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005496277,0.0002878431,0.0002578775,0.001134529,0.0003303854,0.001104575,0.0003159241,0.0002951937,0.001342369],"category_scores_gemma":[0.003091817,0.0002407066,0.0007555352,0.002525538,0.0003376344,0.0006497542,0.0007650987,0.0007134111,0.00009997511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001622962,"about_ca_system_score_gemma":0.000862111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02290081,"about_ca_topic_score_gemma":0.01705893,"domain_scores_codex":[0.9985338,0.0005227528,0.0003585626,0.0001644502,0.0002423769,0.0001780113],"domain_scores_gemma":[0.99608,0.0006748078,0.002600253,0.00006877058,0.000257419,0.0003187784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000771366,0.00003109879,0.9972553,0.00006669552,0.00008685862,0.000219503,0.0001254333,0.0004510937,0.00004012406,0.00003578189,0.0001422018,0.001468822],"study_design_scores_gemma":[0.000004397399,0.00006764744,0.9967982,0.00006050627,0.00004084559,0.0006284799,0.0008519571,0.001188703,0.00005635304,0.00004926402,0.0002437289,0.000009920557],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968879,0.0006929998,0.00009878138,0.0001168757,0.000004600826,0.00001238192,0.0016242,0.000002448491,0.000559743],"genre_scores_gemma":[0.9985781,0.000406822,0.00007030471,0.00002730673,0.000007186785,0.00001728635,0.0007965063,0.000001473925,0.00009493702],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02290081,"threshold_uncertainty_score":0.04553503,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4364376102","doi":"10.1007/s41669-023-00409-y","title":"Economic Evaluation Comparing Virtual Reality with Child Life Programming for Non-sedated Pediatric Medical Imaging: A Cost-Consequence Analysis","year":2023,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Western University; BC Children's Hospital; University of British Columbia","funders":"Mitacs","keywords":"Virtual reality; Psychology; Computer science; Human–computer interaction","authors":[{"name":"John Jacob","is_ca":true},{"name":"Chelsea Stunden","is_ca":true},{"name":"Dhayanand Deenadayalan","is_ca":true},{"name":"Luke Thomas","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06749193653518161,"gpt":0.4162319603709268,"spread":0.3487400238357452,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01523376,0.001306823,0.002151666,0.002705147,0.0003877232,0.002538522,0.001001683,0.0009124559,0.00450293],"category_scores_gemma":[0.04271679,0.0004779249,0.005101602,0.002980941,0.000700585,0.001076231,0.001005324,0.001453356,0.0001322678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01339606,"about_ca_system_score_gemma":0.00910287,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02731346,"about_ca_topic_score_gemma":0.01728607,"domain_scores_codex":[0.9807367,0.0151543,0.000776439,0.0004442691,0.002142742,0.0007454859],"domain_scores_gemma":[0.9736395,0.02098227,0.002190165,0.0003963251,0.002153421,0.0006383538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.07778125,0.004603371,0.08851868,0.01959198,0.02975111,0.001082593,0.000404812,0.5204093,0.001843596,0.02446372,0.007273342,0.2242763],"study_design_scores_gemma":[0.02732653,0.0539329,0.1576344,0.0102174,0.05558942,0.002069412,0.002484935,0.6431345,0.00485944,0.02007909,0.02210908,0.0005628582],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8847894,0.03673865,0.02759323,0.003220748,0.000334131,0.01229423,0.009479666,0.00009065569,0.02545922],"genre_scores_gemma":[0.9822886,0.004823527,0.008667054,0.0002973465,0.0000437427,0.001746604,0.001291104,0.0000123371,0.0008296398],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02731346,"threshold_uncertainty_score":0.09719563,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4286494041","doi":"10.1007/s41669-022-00355-1","title":"Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX)","year":2022,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Oxford University Hospitals NHS Foundation Trust; Dalhousie University; University of Oxford; Health Technology Assessment Programme; Imperial College London; University of Bristol; National Institute for Health and Care Research; University Hospital Southampton NHS Foundation Trust","keywords":"Medicine; Obstetrics; Confidence interval; Gestation; Pregnancy; Pediatrics","authors":[{"name":"Rachael Hunter","is_ca":false},{"name":"Alice Beardmore‐Gray","is_ca":false},{"name":"Melanie Greenland","is_ca":false},{"name":"Louise Linsell","is_ca":false},{"name":"Edmund Juszczak","is_ca":false},{"name":"Pollyanna Hardy","is_ca":false},{"name":"Anna Placzek","is_ca":false},{"name":"Andrew Shennan","is_ca":false},{"name":"Neil Marlow","is_ca":false},{"name":"Lucy C. Chappell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.077040696318964,"gpt":0.366985040062162,"spread":0.289944343743198,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005618446,0.0008395451,0.001730695,0.0005767068,0.00009448414,0.001049364,0.0006993958,0.000893495,0.005398081],"category_scores_gemma":[0.01174757,0.0002997678,0.003599026,0.0005366873,0.0003566946,0.0005984632,0.0008037327,0.001182212,0.0001361801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002204874,"about_ca_system_score_gemma":0.0009151319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003122226,"about_ca_topic_score_gemma":0.002254093,"domain_scores_codex":[0.9955996,0.003724203,0.0001207627,0.0002317016,0.0001816986,0.0001419383],"domain_scores_gemma":[0.9963323,0.002776596,0.0005175945,0.00008377198,0.00008706696,0.0002026481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6135662,0.003443938,0.05432896,0.01253446,0.03668935,0.0004560551,0.0002572545,0.1321912,0.002375932,0.003455072,0.002906887,0.1377947],"study_design_scores_gemma":[0.2345349,0.2431722,0.1933218,0.004087939,0.06620228,0.001073823,0.0007449917,0.2411168,0.003346,0.007157344,0.00497864,0.000263415],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790339,0.0128197,0.002623744,0.0009028473,0.0001147956,0.0009882431,0.001722632,0.00003001369,0.001764078],"genre_scores_gemma":[0.9963776,0.001201364,0.001138956,0.0001164887,0.00002097747,0.0003616171,0.0004210786,0.000003863743,0.0003579542],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005618446,"threshold_uncertainty_score":0.02971357,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4396576727","doi":"10.1007/s41669-024-00484-9","title":"Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients—Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs","year":2024,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"European Organisation for Research and Treatment of Cancer","keywords":"Lung cancer; Quality of life (healthcare); EQ-5D; Medicine; Construct validity; Cancer; Physical therapy; Disease; Psychometrics; Clinical psychology; Health related quality of life; Oncology; Nursing; Internal medicine","authors":[{"name":"Micha J. Pilz","is_ca":false},{"name":"Simone Seyringer","is_ca":false},{"name":"Imad Al-Naesan","is_ca":false},{"name":"Madeleine King","is_ca":false},{"name":"Andrew Bottomley","is_ca":false},{"name":"Richard Norman","is_ca":false},{"name":"Lisa Schlosser","is_ca":false},{"name":"Tobias Hell","is_ca":false},{"name":"Eva‐Maria Gamper","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7914805543456943,"gpt":0.5302336988651476,"spread":0.2612468554805467,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04559607,0.000570447,0.001496308,0.002014758,0.0003070582,0.001037934,0.0007929398,0.0006837633,0.001150586],"category_scores_gemma":[0.05201609,0.0003095773,0.002304194,0.003624548,0.0008611867,0.001001143,0.001666617,0.0006439317,0.0001848699],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001178252,"about_ca_system_score_gemma":0.0006662355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001473194,"about_ca_topic_score_gemma":0.001628844,"domain_scores_codex":[0.9731659,0.02121703,0.002394862,0.001012691,0.001813921,0.0003955796],"domain_scores_gemma":[0.9563599,0.02698954,0.01092687,0.002720365,0.002390304,0.0006129497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05221579,0.0009233843,0.8902109,0.001699485,0.00718391,0.0001746707,0.0005636337,0.00743438,0.00108423,0.0003170648,0.001269738,0.03692279],"study_design_scores_gemma":[0.01009164,0.01159346,0.9672384,0.0002271199,0.003093282,0.0005166193,0.000301183,0.003952987,0.0009355248,0.0002986085,0.001666159,0.00008507176],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935927,0.002424107,0.0007891527,0.00007126679,0.000008355911,0.0005617708,0.001959484,0.000006702813,0.0005864732],"genre_scores_gemma":[0.9946731,0.0002198257,0.0008787519,0.00006304715,0.00001032975,0.0006792081,0.003402299,0.000006172505,0.00006730614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04559607,"threshold_uncertainty_score":0.241138,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2965330563","doi":"10.1007/s41669-019-0159-7","title":"Early Economic Evaluation to Identify the Necessary Test Characteristics of a New Typhoid Test to be Cost Effective in Ghana","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Salmonella and Campylobacter epidemiology","field":"Agricultural and Biological Sciences","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Typhoid fever; Widal test; Test (biology); Economic evaluation; Medicine; Decision tree; Computer science; Salmonella typhi; Artificial intelligence","authors":[{"name":"Samuel N. Frempong","is_ca":false},{"name":"Andrew Sutton","is_ca":true},{"name":"Clare Davenport","is_ca":false},{"name":"Pelham Barton","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05873437870558364,"gpt":0.3704102202133898,"spread":0.3116758415078062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01250382,0.0007709148,0.001155641,0.001035373,0.0002444733,0.002044882,0.0006474738,0.001005093,0.006656462],"category_scores_gemma":[0.04765018,0.0004123873,0.001582036,0.0009763783,0.0005146791,0.001884063,0.0007821017,0.00166575,0.0002295284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006367482,"about_ca_system_score_gemma":0.004576155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008095545,"about_ca_topic_score_gemma":0.005106406,"domain_scores_codex":[0.9929739,0.005950276,0.0001351102,0.0001373359,0.0004186301,0.0003846984],"domain_scores_gemma":[0.9634869,0.03342879,0.001289491,0.0002680324,0.001213497,0.0003133201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.009296509,0.000842143,0.03432248,0.0030696,0.001237058,0.001131446,0.0002487082,0.8038918,0.001829777,0.03333826,0.005184472,0.1056078],"study_design_scores_gemma":[0.001622751,0.004420656,0.04098633,0.001936011,0.001965842,0.0006636794,0.001080729,0.8969139,0.003048695,0.03131211,0.01593483,0.0001144506],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8093759,0.01726274,0.1176597,0.0106649,0.0002651786,0.005000143,0.004742017,0.0001417949,0.03488766],"genre_scores_gemma":[0.9820123,0.001901331,0.0135036,0.0003203874,0.0000255724,0.0004717904,0.0006646223,0.0000104381,0.001090013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01250382,"threshold_uncertainty_score":0.0661273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2943673305","doi":"10.1007/s41669-019-0139-y","title":"A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers","year":2019,"lang":"en","type":"review","venue":"PharmacoEconomics - Open","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Impact; Programs for Assessment of Technology in Health Research Institute","funders":"Mitacs","keywords":"Agency (philosophy); Population; Health care; Business; Family medicine; Medicine; Public health; Cost–benefit analysis; Private sector; Actuarial science; Accounting; Environmental health; Political science; Nursing","authors":[{"name":"Naghmeh Foroutan","is_ca":true},{"name":"Jean‐Éric Tarride","is_ca":true},{"name":"Feng Xie","is_ca":true},{"name":"Fergal Mills","is_ca":false},{"name":"Mitchell Levine","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6885709978218029,"gpt":0.6102526625261878,"spread":0.07831833529561505,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.164319,0.001066574,0.002287788,0.02765248,0.00260977,0.01093192,0.005174256,0.003044222,0.001781616],"category_scores_gemma":[0.3613405,0.001475807,0.002934768,0.03961898,0.00175328,0.003744266,0.002167952,0.004382179,0.0003899061],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06932646,"about_ca_system_score_gemma":0.1447551,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6306078,"about_ca_topic_score_gemma":0.7433005,"domain_scores_codex":[0.8381798,0.04975066,0.02690262,0.003372061,0.07547089,0.00632398],"domain_scores_gemma":[0.6251366,0.1884762,0.02702668,0.004387295,0.1492476,0.005725633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0008885643,0.0001522092,0.0360979,0.0396999,0.002395298,0.0002407725,0.005462313,0.005121002,0.0007344806,0.03053055,0.2113014,0.6673755],"study_design_scores_gemma":[0.0008767979,0.0005016535,0.2435863,0.1438191,0.005043009,0.0004553377,0.009099661,0.006101939,0.002157215,0.01229382,0.5750875,0.0009775196],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06457832,0.6602898,0.01486809,0.143531,0.002539237,0.003986862,0.01748779,0.0003640019,0.09235478],"genre_scores_gemma":[0.4420819,0.4123504,0.07583339,0.04469844,0.001161592,0.004525182,0.01498677,0.0003872605,0.003975099],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9306735,"threshold_uncertainty_score":0.8690125,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2962517794","doi":"10.1007/s41669-019-0161-0","title":"The Costs of Industry-Sponsored Drug Trials in Canada","year":2019,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"Innovative Medicines Canada","keywords":"Cancer drugs; Medicine; Clinical trial; Drug; Business; Pharmacology; Internal medicine","authors":[{"name":"Dat T. Tran","is_ca":true},{"name":"İlke Akpinar","is_ca":true},{"name":"Philip Jacobs","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4439171069277689,"gpt":0.573564349915947,"spread":0.1296472429881781,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008110281,0.0004282303,0.0005053674,0.004658969,0.001323871,0.00350393,0.001121868,0.0006205113,0.004107231],"category_scores_gemma":[0.05034186,0.0003900987,0.001009507,0.007909603,0.0009480746,0.001114907,0.001459474,0.001290142,0.0002966102],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06740198,"about_ca_system_score_gemma":0.08211202,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9254286,"about_ca_topic_score_gemma":0.9471305,"domain_scores_codex":[0.9771844,0.006799042,0.002016809,0.0008573864,0.01058082,0.002561561],"domain_scores_gemma":[0.9483969,0.01208469,0.01514588,0.0008955615,0.01839053,0.005086392],"domain_codex":null,"domain_gemma":"incentives","domain_candidate":"incentives","domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001073386,0.0001971677,0.6656641,0.002635067,0.001889745,0.0006058758,0.0006719629,0.01850422,0.0003371531,0.02115907,0.1024172,0.1848451],"study_design_scores_gemma":[0.0003337926,0.0002760498,0.8508504,0.001903785,0.0008547382,0.0008542566,0.001206578,0.01498057,0.000404401,0.004146338,0.1240757,0.0001133832],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4823608,0.1025913,0.01055494,0.05856461,0.001043044,0.003306824,0.1184563,0.0005187195,0.2226035],"genre_scores_gemma":[0.9478452,0.01995932,0.004165412,0.003590685,0.0003739066,0.0004816938,0.01665954,0.00005580272,0.006868423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9918897,"threshold_uncertainty_score":0.4890379,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}